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Abstract
Thermally Induced Phase Separation (TIPS) method was used to make porous three-dimensional
PLLA scaffolds. The effect of imposed thermal profile during freezing of the PLLA in dioxane
solution on the scaffold was characterized by their micro-structure, porosity (%), pore-sizes
distribution and mechanical strength. The porosity (%) decreased considerably with increasing
concentrations of PLLA in the solution, while a decreasing trend was observed with increasing
cooling rates. The mechanical strength increases with increase in PLLA concentration and also
with increase in the cooling rate for both types of solvents. Therefore, mechanical strength was
increased by higher cooling rates while the porosity (%) remained relatively consistent. Scaffolds
made using higher concentrations of PLLA (7% and 10% w/v) in solvent, showed better
mechanical strength which improved relatively with increasing cooling rates. This phenomenon of
enhanced structural integrity with increasing cooling rates was more prominent in scaffolds made
from higher initial PLLA concentrations. Human adipose derived stem cells were cultured on these
scaffold (7 and 10% w/v) prepared by TIPS at all cooling rates to measure the cell proliferation
efficiency as a function of their micro-structural properties. Mean pore-sizes played a crucial role
in the cell proliferation than % porosity since all scaffolds were > 88 % porous. The viability of
human adipose tissue derived adult stem cells cultured on 7% PLLA scaffolds cooled at 10˚C/min
was also shown to be comparable with corresponding culture conditions without scaffolds for a
period of 42 days. Scaffolds made from 10% PLLA in dioxane and cooled at 10°C/min favored
cell proliferation compared to scaffolds made from other parameters. This structurally
characterized scaffolds for bio-response was used for osteogenic studies and found that PLLA
scaffolds are ‘osteoinductive’ when cultured in stromal media in vitro. Osteo-conductivity of
PLLA on hASCs was further enhanced with osteo-inductive media.
xi

Chapter 1 : A Review of Biomaterials used in Scaffolds for Osteochondral Grafting
1.1. Introduction
A remarkable phenomenon of human skeletal system is its restorative healing capacity with
immobilization [1]. However incomplete healing can occur in specific sites of injuries at lower
limb joints. This leads to a condition called psuedoarthrosis, where complete bone fusion to its
original form is impossible without surgical implantation of external grafts [2]. Three-dimensional
scaffolds are used to make tissue engineered bone grafts for treating traumatic defects by surgical
implantation [3] and by controlled drug delivery [4]. In rare cases bone grafting was used to treat
tumors by curettage and cementation methods [5]. Scaffolds used in making such implantable
grafts is that it should micro and macro-structurally mimic the recipient host tissue. Moreover, the
scaffolds material should be bio-compatible providing no cytotoxicity as well as facilitating in
vivo integration after implantation. The pore-size and porosity play a crucial role in cellular growth
and differentiation of progenitor cells (stem cells) [6]. A viable bone graft should possess the
following integral properties: Osteo-induction: Induce the differentiation of osteo-progenitor cells
(stem cells) into osteogenic lineages; Osteo-conduction: Favorably influence the proliferation of
osteoblasts and blood vessel incursion leading to the formation of osteoid; and Osteo-genic: The
implanted graft material should itself integrate with the host bone simultaneously maintaining the
viability of cells.
First described bone grafting was in 1668. A cranial defect of an injured soldier was repaired using
dog’s skull [7]. An ever-increasing demand for bone grafting has followed since then (due to
trauma, tumor excision, spinal fusion etc.,) calling for expanded research for skeletal
reconstructions. Musculoskeletal defects restricted the lives of over 1.5 million Americans in 2015
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and the numbers have only increased during the intervening years [8]. About 2.2 million bone
grafting procedures are done worldwide annually [9]. Many of these disorders require surgery to
accelerate or improve bone repair. One common example is spinal fusion surgery recommended
to treat back pain secondary to scoliosis, spinal stenosis, degenerative disc disease, infectious
processes, tumors, and trauma. At present, the “gold standard” for spinal fusion repair is
autologous bone, usually harvested from the iliac crest of the individual [10]. Nevertheless, this is
far from a perfect solution.
Autografts (previously known as homografts) are the most osteogenic material containing live
osteocytes, increasing the chances of fusion. Although autografting may seem like a convenient
ideal method for bone grafting, they are limited by numerous practical disadvantages. High chance
of morbidity in the donor (iliac crest, rib, fibula etc.,) as well as host (injured) sites. Rates of
psuedoarthrosis are from 5 to 35% in the healed site. These are only further complicated by low
availability, risk of blood loss and transfusion, increased surgical time and cost [11]. In 30% of
patients, the donor site becomes infected, bruised, fractured, or painful following the surgery [12].
Indeed, when a patient requires autograft bone for multiple spinal fusions, the iliac crest may not
provide sufficient material [13]. While there are alternative materials available all face a common
limitation; none display osteogenic capability. Allograft bone from cadavers can be sterilized,
stored, and used in the operating room as needed. These materials can be pre-shaped for specific
use or powdered, allowing them to be applied as a paste at the surgical site [14]; however, allografts
can cause inflammation, elicit an immune response, and have been an infectious source in a limited
number of cases [15]. Because allograft bone is sterilized, it no longer contains viable native bone
forming cells (osteoblasts, osteocytes) and lacks osteogenic properties. In clinical trials, allograft
bone is inferior to autograft bone in multilevel spinal fusions [16].
2

A group in National University of Singapore collaborating with Temasek Polytechnic has
developed, calibrated, and patented a novel PCL-Ceramic (HA/TCP) using Fused Deposition
Modelling (FDM) technique. These FDM fabricated implants are being used as burr hole plugs in
cranioplasty and to re-generate iliac crest after autograft was taken. Clinical outcomes were
positive with no patients developing adverse side-effects a year after surgery [17]. Therefore, it is
extremely important to have better understanding of various factors involved in tissue engineering
a viable bone graft. This review reports some commonly used materials and methods intended to
make bone grafts and their in vivo outcome on some mammalian species.
1.2. Scaffold Materials: Ceramics and Polymers
Ceramics like Tri-calcium phosphates (TCP) (Ca3(PO4)2) have been used in bone repair for the
past 80 years [18]. The stoichiometry of TCP is similar to amorphous precursor to inorganic
composition of bone. A significant advantage of α and β-tricalcium phosphates is its solubility in
water, enhancing in vivo degradation [18]. However, βTCP does not dissolve in vivo at
physiological pH levels. It requires acidic pH levels caused by cell activity [19]. α and β-tricalcium
phosphates have similar chemical composition, however they have different crystallographic
structures, making αTCP more soluble in water. αTCP is obtained by heating βTCP at high
temperatures (1150°C) followed by quenching [20]. Most common bone scaffolds made from
βTCP has porosity ranging 35 - 50 % and pore-sizes ranging 100 - 300 µm [21].
Hydroxyapatite (HA) (Ca10(PO4)6(OH)2 - crystal unit) is another commonly used calcium
orthophosphate compounds [18]. This preference is due to its stoichiometric similarity to minerals
naturally present in bones. A variety of bone substitutes made of HA are available commercially
like Pro Osteon 500R (Interpore Cross International, Irvine, CA, USA), Bio-Oss® (Geistlich
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Pharma North America Inc., Princeton, NJ, USA) and Endobon® (Zimmer Biomet, Palm Beach
Gardens, FL, USA) [22]. Pro Osteoan 500R is made by de-mineralizing natural coral exoskeletons
and hydrothermal conversion of calcium carbonate into calcium phosphate. Incomplete
conversions result in external HA and internal calcium carbonate which are more resorbable [23].
The resorption rates of HA in vivo is very low at 5 - 15% per year [21].
HA are comparatively more crystalline than βTCP. Hence scaffolds made from HA has higher
mechanical strength comparable to cancellous bone. However, βTCP promotes in vivo
degradation. To combine the advantages of these two compounds, composites of βTCP and HA
(biphasic calcium phosphates) are used as scaffold materials. The resorption of the implants
depends on the composition of βTCP : HA. Most common compositions of either of these
compounds are 40 - 60 %. Some commercially available bone substitutes are Triosite (Zimmer
Biomet, Palm Beach Gardens, FL, USA) and BCP bone void filler (Medtronic Sofamor Danek
USA, Inc., Memphis, TN, USA) [18].
Basically, sintering process or a minor modification of the same is used to make pure ceramic
scaffolds. The micro-structural property in such methods are partially controlled by using a
negative mold made of industrial foam like polyurethane. This mold will be simultaneously
removed during the heating process. A combination of gel casting and polymer sponge mold was
used to make porous HA scaffolds by sintering at 1350°C for 2 hours [24] by Ramay et al,.
Alternatively, phase separation method was adopted by Fukasawa et al., by freeze-drying water
based ceramic slurry [25]. In general, the pore sizes of such scaffolds were in the order of few
hundred µm to few millimeters. But the porosity will be as low as 30 - 40 %. This combined with
the low bio-degradability of materials like HA, led the scientists to study bio-degradable polymers
for bone grafts.
4

Polymers can be divided into two major categories: naturally available polymers like
polysaccharides (starch, alginate, chitin/chitosan, hyaluronic acid derivatives) or proteins (soy,
collagen, fibrin gels, silk) [26] and synthetic bio-degradable polymers (PLA, PGA and PCL). This
book chapter will focus synthetic bio-degradable polymers, due to its compatibility to bone graft
synthesis. Scaffolds made using synthetic polymers can be produced under controlled conditions
with predictable and reproducible mechanical (compressive/tensile strength and modulus) and
structural properties (pore-sizes, pore shapes and porosity (%)). Moreover, using synthetic
polymers, averts the risk material impurities and toxins in the bone graft, which leads to immune
rejections in the host.
Some commonly used synthetic polymers used to make tridimensional scaffolds for bone tissue
engineering are saturated poly-α-hydroxy esters namely, poly (lactic acid) (PLA) and poly
(glycolic acid) (PGA), as well as poly (lactic-co-glycolide) (PLGA) copolymers [27]. PLA exists
in three forms: l-PLA (PLLA), d-PLA (PDLA), and racemic mixture of d,l-PLA (PDLLA).
PGA is a simplest linear aliphatic polyester. This was first synthesized as an absorbable suture
material under the trade name Dexon. PGA is not soluble in most organic solvents, due to their
high crystallinity (46-50%) except highly fluorinated organic solvents such as hexafluoro
isopropanol [28]. Jeon et al., 2008 [29] cultured hASCs on 2D and 3D PLGA scaffolds (200300μm pore size) fabricated by solvent casting and particulate leeching technique, in osteogenic
media. Mineralization in extracellular matrix and expression of late bone marker genes (bone
sialoprotein and osteocalcin) were observed after 2 weeks of osteogenic induction.
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Figure 1.1. Synthesis of (A) Poly (glycolic acid) (PGA), (B) Poly (l-lactic acid) (PLLA), (C)
Poly (ɛ-caprolactone) (PCL) and (D) Poly (lactic-co-glycolic acid) (PLGA) (Adapted from Ref.
[30])

PLA is a biodegradable thermoplastic aliphatic polyester derived from renewable resources, such
as corn starch, tapioca roots or sugarcane. Poly-lactic acid is in fact a polyester and not a polyacid.
Poly-L-lactide (PLLA) is the product resulting from polymerization of L,L-lactide (also known as
L-lactide). PLLA has a crystallinity of around 37% (Poly-L-lactic acid and Poly-D-Lactic acid are
semi-crystalline), a glass transition temperature 60–65 °C, a melting temperature 173–178 °C and
a tensile modulus 2.7–16 GPa [31]. PLLA is soluble in chlorinated solvents, hot benzene,
tetrahydrofuran, and dioxane.
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Table 1.1. Bio-degradation and mechanical properties of synthetic polymers (adapted from Ref.
[32])
Polymer

PDLLA

Bio-degradation time

Compressive* or tensile

(months)

strength (MPa)

12 - 16

Pellet: 35 - 150*

Modulus (GPa)

Film or disk: 1.9–2.4

Film or disk: 29–35
PLLA

> 24

Pellet: 40 – 120*

Film or disk: 1.2 – 3.0

Film or disk: 28 – 50

Fiber: 10 – 16

Fiber: 870 – 2300
PGA

6 - 12

PLGA

Adjustable: 1 - 12

PCL

> 24

Fiber: 340 – 920

Fiber: 7 – 14

41.4 – 55.2

1.4 – 2.8

-

-

A specific advantage of using these synthetic polymers is its natural bio-degradability. After
surgical implantation, these materials undergo a hydrolytic degradation in vivo through deesterification (hydrolysis of ester bonds). The resulting monomeric products (lactic and glycolic
acids) undergo natural pathways to be excreted from the body. PLA is known to be cleared through
tri-carboxylic acid cycle. Bio-degradation time of PLGA can be adjusted significantly by adjusting
the lactic and glycolic acid component ratio [33]. PGA undergoes faster degradation at lower pH
levels [34].
Poly(ε-caprolactone) (PCL), an important member of the aliphatic polyester family, has been used
to entrap antibiotic drugs. Thus, a composite of PCL and antibiotic drugs can be considered as an
7

effective drug-delivery system [35]. These composites can be used in the treatment of bone defects
by enhancing bone ingrowth and regeneration. The degradation mechanism of PCL is similar to
that of PLA undergoing a hydrolytic degradation of ester bonds. However, the degradation time
for PCL is higher compared to other polymers taking up to several years in some cases [36].
The degradation times given in Table 1 represents a collection of observed data so far from various
literatures. However, the actual degradation times of the grafts in vivo would depend on a lot of
factors such as: pore morphology, porosity (%), mechanical strength, crystallinity, molar mass
(Mw) and polydispersity (Mw/Mn). In general, the degradation rates are as follows [32]:
PGA > PDLLA > PLLA > PCL
When using, PLA and PGA or its other forms (PLLA, PDLA, PLGA) as scaffold materials for
bone tissue engineering, there is always a risk of bulk degradation causing the implant to fail prematurely. This quick degradation causes an influx of acidic by products which may lead to
inflammatory responses in the host tissue [37].
1.3. Scaffold Fabrication Methods
1.3.1. Solvent-Casting and Particulate Leaching Technique
In this method of fabricating scaffolds, water soluble salt (e.g. sodium chloride, sodium citrate)
particles are mixed into a biodegradable polymer solution. The solvent is then removed by
lyophilization. The salt particles are leached out to obtain a porous structure. The advantages of
this method are: simple operation, ability to control pore size and porosity by varying the
salt/polymer ratio and particle size of the added salt [38].
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1.3.2. Gas-Foaming Process
In this method, solid polymer disks are saturated with high pressurized CO2. Releasing CO2 gas
from the polymer system causes thermodynamic instability. This makes the CO2 bubbles to grow
inside the composite forming a 3D porous polymer structure. By this technique scaffolds of ~ 93%
porosity and pore size of ~100μm can be fabricated. No organic solvents are used in this method.
The disadvantage in this method is that interconnectivity of pores is too low [39].
1.3.4. Electrospinning Technique
A polymer solution or melt is induced with an electric potential. At a critical voltage, the charge
imbalance overcomes the surface tension forming a polymer jet. This jet is directed onto a substrate
as the solvent evaporates and polymer fibers are formed. Localized control on the micro-structure
of the porous scaffold can be achieved. Only disadvantage of this method is it is very tedious to
make a 3D scaffold of considerable thickness. Scaffolds made by this process are usually sheets
with thickness in microns [40].
1.3.5. Thermally Induced Phase Separation (TIPS)
This is a simple procedure in which, the polymer is first dissolved in a solvent at a higher
temperature. Liquid–liquid or solid–liquid phase separation is induced by lowering the temperature
until the composite is frozen. Frozen solvent is sublimated by maintaining low pressure and
temperature leaving a porous polymer scaffold. The pore morphology of the scaffolds varies
depending on the concentration of the polymer solution and induced thermal profile during
freezing process. Usually scaffolds fabricated by this method have good mechanical properties.
Ma et al., 2001 [41] observed that PLLA scaffolds fabricated using this technique has a
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compression modulus about 20 times higher than that of the scaffold fabricated using other
methods. This method usually generates scaffolds with a pore size of 30–150 µm [41].
1.3.6. Solid Freeform Fabrication (SFF)
Computer-aided design (CAD) models are used to tridimensionally print a polymer scaffold of
pre-design micro and macro structures. One early form of SFF known as Rapid Prototyping
Technique (RPT) was first developed and published by Bredt et al., 1990 in Massachusetts Institute
of Technology, Cambridge, MA, USA [42]. Polymer jet is targeted on a substrate similar to inkjet printing, forming complex 3D scaffolds of sequential layers. Scaffolds using low molecular
weight PLLA was used to print scaffolds of tensile strength up to 17 MPa [43]. However, the
practical disadvantage of this method thick layers of scaffold material which are determined by
the thickness of the polymer jet. This essentially decreases the overall porosity (%) of the scaffold.
Coupling SFF method with other conventional scaffold fabrication process (solvent - casting,
phase separation, gas foaming) could give an ideal scaffold with distinguishable micro and macroporous structures at the same time increasing the porosity. In 2002, Xiong et al., from Tsinghua
University, Beijing, China, developed such a combination method. PLLA/TCP/dioxane
composites were printed using low-temperature deposition method (LDM). By this method, the
measured porosity values were about 90% [44]. These PLLA/TCP composite scaffolds loaded
with bovine bone morphogenic protein (bBMP) was implanted into to repair 20 mm segmental
defects in canine radiuses. The defect was found to be completely cured at 24 weeks after
implantation. Long fabrication time and high costs of manufacture are critical limiting factors for
using this technique. This is the reason, majority of in vitro and clinical studies for bone grafting
uses conventional scaffold fabrication techniques.
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Figure 1.2. Schematic illustrations of basic scaffold fabrication techniques. (Adapted from Ref.
[45])

1.4. Structural Requirements of a Scaffold
Vascularization remains a problem for successful fusion of larger grafts (order of mm in
dimensions) in vivo. Implanted bone grafts depend on blood vessels for nutrients, oxygen and
growth factors during the initial stages of fusion. The three-dimensional architecture (pore-size,
porosity and inter-connectivity of pores) of the scaffold used should facilitate spontaneous vascular
ingrowth, failing which may lead to cell death due to hypoxia in the interior portions of the graft
[46]. Necessity of graft implantation occurs primarily to treat large sized defects (order of mm).
Hence it is implied that the micro-structural properties of scaffolds should resemble that of
cancellous bone also.
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Table 1.2. Structural properties of scaffolds made from various techniques
Pore-size

Scaffold material /

Porosity (%)

Compressive
Modulus (MPa)

Fabrication method
Min

Max

Min

Max

Min

Max

300 μm

1 mm

25

80

3

50

67

97

0.15

0.3

46.8

78.4

100

1800

-

-

1.09

20

Non-3D printed
ceramic scaffolds [4749]

Polymers / Gas
foaming [50, 51]
Ceramics / Gas

100 μm (439
10 μm

μm with salt
leeching)

100 μm

400 μm

Polymers / Electro-

0.11 μm

1.19 μm (fiber

spinning [54, 55]

(fiber dia)

dia)

Polymers / TIPS [56, 57]

50 μm

100 μm

71

91

0.15

6.2

Cancellous bone [58]

300 μm

600 μm

75

85

100

300

Cortical bone [58, 59]

10 μm

50 μm

5

10

18,000

22,000

foaming [52, 53]

From Table. 2, it can be observed that, very few synthetic polymer based fabrication techniques
provides the necessary pore-sizes. However, porosity values are sufficiently higher which may
cause more uniform degradation in vivo. In terms of mechanical strength, it will be necessary to
rely on other support structures to with stand the compressive/tensile stresses at the defect site.
Loads within a human intra vertebral disc can reach a maximum of 4MPa [60]. The young’s
modulus of a human cortical bone is ~35 GPa and cancellous bone varies between 50-500 MPa
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[61]. However the % porosity and mean pore-size of most synthetic polymer scaffolds are
comparable to that of a cancellous bone (90%) [62, 63] and pore size (~ 50 μm) [64]. Using these
scaffolds in conjunction with calcium phosphate cements (CPC) may be the solution [65]. Though
biologically inert [11], CPC is extensively used to harden material/fillers to treat minor skeletal
defects [66].
1.5. Current Bone Tissue Engineered Scaffold Models
In recent years, extensive research is being done on scaffold assisted bone regeneration using
synthetic materials. Using BMSCs (Bone Marrow Stem Cells) or osteoblasts on synthetic materials
on mammals (mouse, rats and rabbits) is the common model of invitro study [67, 68]. In 2004,
Lendenckel et al. successfully treated and healed a calvarial defect of a 7-year old girl using hASCs
due to lack of enough autologous cancellous bone from iliac crest [69]. Still ethical reasons prevent
testing the scope of hASCs combined with a synthetic material on treating skeletal defects in
human species [70].
1.5.1. Synthetic Polymer Models
On-site delivery of bone marrow stem cells (BMSCs) using a porous polyethylene glycol–
polyurethane (PEG–PU) scaffold to the injury site bearing the therapeutic potency of BMSCs.
Though no differentiation pathways were performed, this study re-emphasizes the retention of
stem cells characteristics in vivo by measuring Oct-4, Sox-2, Klf-4, c-Myc along with nestin,
CD49f, CD29, CD73, CD44 and Sca-1 gene expressions [71, 72]. PCL scaffolds were
manufactured by electrostatic fiber spinning method by making a polymer solution of PCL in
chloroform. Mesenchymal Stem Cells (MSCs) derived from bone marrow of neonatal rats (3 – 7
days old) were loaded on the scaffold (pre-soaked in purified collagen) by mechanically pressing
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the cell pellet on the scaffold. The electro spun PCL scaffolds exhibited mineralized bone tissue
formation and three-dimensional cell penetration. The shape-ability of such tissue engineered bone
grafts in surgical applications for treating defect sites was emphasized [40].
Three-dimensional 75:25 PLGA scaffolds were fabricated by solvent casting particulate leeching
method. 12.5 mm in diameter and 6 mm in height. Porosity of 79%. MSCs loaded on top of the
scaffolds were cultured in a spinner flask and a rotating wall vessel in addition to static conditions.
This was done to study if mitigated nutrient transfer from the media outside the scaffold boundary
influenced cell proliferation and differentiation inside the scaffolds. Interestingly, spinner flask
showed comparatively higher cell proliferation and significantly high calcium deposition
(representing high expression of ALP and OC genes) compared to static culture. On the other hand,
rotating wall vessel setup exhibited relatively lower cell proliferation and differentiation. However,
in all three culture systems, inhomogeneous cell distribution was observed with high cellular
density on the surface and considerably lower density on the interior. This indicated that the microstructural properties of the scaffold itself could determine the three-dimensional cellular growth
inside the scaffolds [73].
In situ forming scaffolds eliminate the complexity of fabricating complex geometries ex vivo. Poly
(methyl methacrylate) (PMMA) bone cements are the most widely used injectable and in situ
forming materials in orthopedics. Hydrogel disks (10 mm diameter and 1 mm thick before
swelling) were fabricated with 10 wt% PEGDA in phosphate buffered saline (PBS) with the
addition of no Acr-PEG-RGD, 0.5 mM Acr-PEG-RGD, 5.0 mM Acr-PEG-RGD, and 5.0 mM AcrPEG-RDG. Osteoblasts were seeded onto sterile disks at a density of 5×104 cells/cm2 [74].
Commercially available PLGA scaffolds (GC corporation, Itabashi-ku, Tokyo, Japan) of 5 mm
diameter and 1.5 mm thick were used to heal large cartilage defects in rabbit knees. These scaffolds
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were loaded with BMSCs obtained from isolated from the humeral head of each rabbit and cultured
in vitro overnight before surgically implanting into the defect areas of the same rabbits. After 4
and 12 weeks of implantation, the defect sites were histologically analyzed. It was found that the
implant had fused successfully into the host bone providing architectural support. However in vivo
chondrogenesis was hinted without dedicated study for gene markers [75].
Membranes made from nanofibers of PLGA was fabricated by electrospinning technique by
dissolving PLGA in N,N-dimethylformamide (Junsei, Tokyo, Japan) and tetrahydrofuran (Junsei)
solution at 25% (wt). Lactic acid / glycolic acid content ratios were 75 : 25, 50 : 50 and a blend of
75 : 25 and 50 : 50. Chondrocytes isolated from porcine articular cartilages were cultured on these
polymer membranes to study their cellular response in terms of cell proliferation and cytotoxicity.
ECM formation (indicative of chondrogenesis) was evaluated by measuring glycosaminoglycans
(GAG) content. Chondrocytic phenotype was aspired to be maintained bymeans of mechanical
stimulation as intermittent hydrostatic pressure (IHP). The mechanical strength (tensile modulus,
ultimate tensile stress/strain) of these nanofibers based scaffolds were comparable with human
skin and lower than cartilage. Faster degradation of 50 : 50 PLGA scaffolds were observed which
may be attributed to the hydrophilic nature of glycolic acid content [76].
A custom hybrid poly-(lactic-co-glycolic acid) (PLGA)–gelatin/chondroitin/hyaluronate (PLGA–
GCH) scaffold was developed to evaluate its chondrogenic potential relative to PLGA scaffolds.
PLGA scaffolds were developed by low-temperature deposition method (LDM) [44]. The idea was
to hybridize PLGA scaffolds with GCH miming the hyaline cartilage ECM composition (15–20%
collagen type II, 5–10% chondroitin sulfate, 0.05–0.25% hyaluronan). Cell proliferation and ECM
formation was significantly higher in PLGA-GCH hybrid scaffolds than control PLGA at 24 days
in vitro. At 24 weeks post-operation, the hyaline repair was more tenacious and ill-demarcated in
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PLGA–GCH group at the repair interface [68]. PLGA scaffolds were fabricated by molding and
leeching process combined with sieved NH4HCO3/NaCl (1:1) particulates of two different size
ranges (125–180 and 300–500 μm) and chloroform. Three groups of such scaffolds were surface
modified with 0.2% (V/V) pig-skin collagen type I (Life Technologies, Grand Island, NY), 2%
(W/V) chitosan (Mol. Wt.: 880,000; degree of deacetylation: 90%) (Kiotek, Taiwan) and 10%
(W/V) N-succinyl-chitosan solutions. The results showed that collagen increased sell attachment
and proliferation while decreasing osteogenic differentiation compared to the chitosan and Nsuccinyl-chitosan modifications [77].
PLGA scaffolds of 7mm in diameter and 4mm in thickness with 90% porosity were prepared by
solution-casting/salt-leaching method. In vitro degradation analysis shows that it lost around 60%
of its original mass at 20 days. Cell attachment study shows that only 37% of the initial loaded
cells attached to the scaffolds at day 1. After 2 weeks, calcification was observed in vitro for
osteogenic induction medium. Critical size osseous defects of 12 × 5 mm were made on the
mandible of 12 mature White New Zealand rabbits (2.5 kg). Tissue engineered PLGA/MSCs
composites were implanted into the defects in the experimental group and just PLGA scaffold in
the control group. After 6 or 12 weeks, all rabbits were euthanized for histological examinations
of healed sites. It was observed that the defects can be completely cured with tissue engineered
PLGA/MSCs graft after 3 months of implantation. On the contrast, blank PLGA showed very little
healing [78]. PLGA and PLGA/PVA scaffolds were developed by melt-molding and particulate
leeching method. In vitro and In vivo degradation were focused in this study. Hydrophilic addition
of PVA fosters the degradation rate of these scaffolds both in vivo and in vitro for short term.
However, during long term (4 weeks), the total degradation between the test samples of PLGA and
PLGA/PVA wetted and pre-wetted were not significant [79].
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Bone marrow stem cell knitted PLGA scaffolds were used to treat tendon defects in New Zealand
White rabbits with single sutures as control. Histological examinations were done after 2, 4, 8 and
12 weeks of implantation. In vitro cultures of BMSc combined with PLGA shows. Type I and type
III collagen fiber formation was observed in in vitro cultures of BMSCs combined with PLGA and
at 4 weeks post-surgery in New Zealand White rabbits [80]. Blended 3D scaffolds of PCL/PLGA
were fabricated using Solid Free Foam technology. Compressive strength was determined as the
maximum stress (0.8 MPa) from where the linearity of stress-strain curve deflects. Compressive
stress modulus of such scaffolds was 12.9 MPa and the porosity was 69.6%. MC3T3-E1 cells were
cultured on these scaffolds with standard culture media (DMEM, 10% FBS) for 15 days with
consistent cell proliferation [81].
PLGA scaffolds were fabricated by solid-liquid phase separation method for oriented microporous structures or non-oriented micro-porous structures using NaCl particles as porogeny. In the
oriented group pores were parallelly longitudinal in the vertical section and uniformly distributed
in the cross section. In the non-oriented group pores where spherical and non-homogenous in sizes.
There was no significant difference between volume or porosity of scaffolds between the two
groups. However, scaffolds of oriented porous structures show increased compressive modulus
(~7MPa) relative to non-oriented porous samples (~3MPa). Also, oriented porous structures had
more homogeneous cellular growth than the non-oriented porous structures in vitro. Thickness and
volume shrinkage was observed to be lesser in oriented group than non-oriented group fabricated
by NaCl porogens. Additionally, oriented groups had more cartilage specific ECM deposition after
12 weeks of in vivo implantation in nude mice. These crucial results emphasize the importance of
homogeneity of pore sizes and structures in tissue engineered scaffold [82].
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Table 1.3. Current osteo-chondrogenic models
Scaffold Material

Cell type

Species

PLLA

BMSCs

Male human

(PEG)–PLLA

MC3T3-E1 cells

Mouse calvaria

mPEG-PCL gel

Polymers

Fisher rat

5 × 105 /
scaffold
6 × 105 /
scaffold
2.5 × 105 /
scaffold

Study type

Pathways

Gene markers

Period of culture

References

In vitro

Chondrogenesis

SOX-9, COL1A1,
COL2A1, Aggrecan

4 weeks

[60]

In vitro

-

-

4 weeks

[83]

OS

ALP

3 weeks (In vitro),
4 weeks (In vivo)

[84]

10 days

[72], [71]

In vitro / In
vivo

polyethylene glycol–
polyurethane (PEG–PU)

BMSC

C57BL/J6 mice

5 × 105 /
scaffold

In vitro / In
vivo

Engraftment

Sca-1, CD11b,
CD29, CD133 and
CD140a

PLGA

Chondrocytes

Newborn swine

5 × 107 / cm3

In vitro / In
vivo

-

-

12 w (In vitro), 12
w (In vivo)

[82]

BMSCs

Lewis rats

4 × 106 /
scaffold

In vitro

OS

ECM, Calcification

4 weeks

[40]

75:25 PLGA

MSCs

Male Sprague–Dawley rats

106 / scaffold

In vitro

OS

ALP, OC

21 days

[73]

Poly (ethylene glycol)diacrylate (PEGDA)

Calvarial
Osteoblasts

Rats

4

5×10 / cm

In vitro

OS

-

4 weeks

[74]

Male Japanese white rabbits
(3–4 kg)
Male Sprague-Dawley rats
(200–250 g)

1×107 cells /
cm3

In vitro / In
vivo

Chondrogenesis

-

12 h (In vitro), 12
w (In vivo)

[75]

PCL

PLGA

BMSCs

PLGA/PVA

-

Modified PLGA

Osteoblastic
stromal cells

PLGA
PCL/PLGA
PLGA

Polymer-Ceramics

hADSCs

Cell loading
density

2

-

In vivo

-

-

4 weeks

[79]

Sprague-Dawley rats

7 × 104 /
scaffold

In vitro

OS

ALP, Ca deposition

14 days

[77]

MSCs

White New Zealand rabbit

105 / scaffold

In vitro / In
vivo

OS

Ca deposition

20 d (In vitro), 12
w (In vivo)

[78]

MSCs (MC3T3E1)

Mouse

-

In vitro

-

-

15 days

[81]

Porcine

5 × 104 /
scaffold

In vitro

-

ECM

14 days

[76]

107 / scaffold

In vitro / In
vivo

Chondrogenesis

ECM

8 h (In vitro), 24
w (In vivo)

[68]

1 × 107 / graft

In vivo

Tenogenesis

-

12 weeks

[80]

5 × 103 /
scaffold

In vitro

OS

ALP

5 days

[85]

Chondrocytes

PLGA–GCH

BMSCs

PLGA

BMSCs

Poly(caprolactone) (PCL)
(nanofibers), hydroxyapatite
(HAP)

L-929 fibroblast
cells

Mature New Zealand white
rabbits (2.5 - 3 kg)
Female New Zealand White
rabbits
Mouse

5

PLLA/Apatite/Collagen

Saos-2

Female Human

1 × 10 /
scaffold

In vitro

-

ALP

8 days

[86]

nano-HA/ collagen/PLA

Osteoblasts

Rat calvaria

5 × 104 / cm2

In vitro / In
vivo

-

-

16 weeks

[87]

In vitro

OS

-

35 days

[88]

8 weeks

[89]

8 weeks

[90]

5

PolyHIPE Polymer

Osteoblasts

poly-ε-caprolactone
(PCL)/CaP

BMSCs

PLGA/HA

Calvarial
Osteoblasts

Rat

300 x 10 /
scaffold

Human

3×10 / scaffold

In vitro

OS

Ca deposition. OC,
collagen - I

Rat

2.0×106 /
scaffold

In vitro / In
vivo

-

Ca deposition

5
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Scaffolds of dual-sized pore structures were fabricated by incorporating montmorillonite (MMT)
(a family of phyllosilicates (2:1) that comprise of two tetrahedral silica thin layers with a central
octahedral sheet of magnesia) into a PLLA solution. To obtain the final scaffolds, electrospinning
and salt leaching/gas foaming methods were adopted in this study. It was observed that the
degradation of scaffolds in terms of weight loss and molecular weight decrease of PLLA was
enhanced by the presence of MMT over a course of 40 days. Particularly, the molecular weight
underwent a sharp decrease from 110,000 to 10,000 from 5 to 15 days. However, there were no
significant difference between pure PLLA scaffolds and MMT infused nanocomposite models in
decrease of molecular weight over a period of 40 days. Significant difference in weight loss was
observed with PLLA/MMT nanocomposite scaffolds [91].
PLLA scaffolds were formed by solvent casting and particulate leaching, simultaneously
incorporating NaCl particles as porogens. The median pore diameter of such scaffolds was
62.44mm and the porosity was 90.4%.
Human bone marrow stem cells were cultured on these scaffolds aimed for a viable clinical
application as a treatment for either osteoarthritic cartilage injury or the degenerate inter vertebral
disc (IVD). It was found that differentiated BMSCs in combination with SOX-9 transfection would
establish tighter chondrocytic phenotype. Additionally, pre-differentiated BMSCs when cultured
on PLLA scaffolds, synthesize and similar matrix molecules as in vivo [60].
Macro-porous poly(l-lactic acid) (PLLA) scaffold was fabricated from a PLLA–dioxane–water
ternary system with added polyethylene glycol (PEG)–PLLA using thermally induced phase
separation (TIPS) method. Cloud-point temperatures of various compositions of (PEG)-PLLA was
observed to increase with increasing concentrations of PLLA. MC3T3-E1 cells (osteoblast-like
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cells derived from mouse calvaria) were cultured on these three-dimensional constructs for 28
days. Addition of amphiphilic diblocks helped in the fabrication of interconnected scaffolds
without segregation or sedimentation. Such macro-porous scaffolds induced high cell proliferation
for the culture period studied [83]. PLLA scaffolds of 95.65% porosity were fabricated by solidliquid phase separation method, with no controlled cooling profiles before sublimation process. A
subset of these scaffolds were immersed/coated with simulated body fluid (SBF) or simulated body
fluid with collagen (SBFC). Saos-2 osteoblast-like cells were loaded and cultured on these
scaffolds to measure their viability and ALP activity at 8 days. Scaffolds made with apatite coating
and composite coating expressed more ALP activity and viability than PLLA [86].
1.5.2. Polymer-Ceramic Models
PLLA scaffolds fabricated by thermally induced phase separation method were hybridized with
nano-hydroxy apatite (NHAP) or micro-hydroxy apatite (MHAP) at different compositions of
NHAP. Two different quenching temperatures were used before sublimation to study their
structural integrity as well as different composition of solvent (dioxane/water). The compressive
modulus of the scaffolds increased as expected with increasing NHAP/MHAP concentrations. But
100% dioxane had the highest compressive modulus (~8.5 MPa) compared to water substitutions
in solvent [92].
To mechanically strengthen nano-hydroxyapatite/collagen (nHAC) composite, a novel nanoHA/collagen/poly(lactic acid) (nHAC/PLA) was developed by adding PLA to the mixture. A
combination of molding and solid liquid phase separation method was adopted at a quench
temperature of -20°C before lyophilization. The compressive modulus of these composite
scaffolds was highest (~45MPa) when PLA composition was 10% in solvent. PLA concentration
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of 8% and 12% had a modulus of 20 MPa and 40 MPa respectively. The ultimate compressive
strength of 8, 10 and 12% PLA were 1.3, 1.5 and 1.85 MPa respectively. These scaffolds were
loaded with osteoblasts derived from calvaria of neonatal rats before implanting into 15 mm
segmental defect in the right forelimb of New Zealand adult rabbits (2.5–3 kg). The porous
scaffolds mimicking the natural cancellous bone in terms of composition and microstructure was
found to be biologically active when implanted in vivo [87].
Mineralization of Shish-Kebab structure of Hydroxyapatite on poly(e-caprolactone) (PCL)
nanofibers following NFSK (Noncoherent Frequency Shifting Key) pattern by incubating in
calcium induced cell culture medium and SBF (Simulated Body Fluid). A comparative tensile
strength analysis of aligned and randomly oriented mats was done for PCL, NFSK and mineralized
NFSK models. Results showed that the randomly oriented structures showed lower ultimate
strength for all models. Aligned mineralized NFSK had the highest young’s modulus (22.5 MPa)
followed by aligned NFSK (10 MPa), followed by aligned PCL nanofibers (2.5 MPa). Fibroblasts
(L-929) cells were cultured on these pre-mineralized structures to characterize its cytotoxicity and
morphological changes. NFSK scaffolds showed similar cytocompatibility as PCL nanofibers
[85]. A porous construct was developed by high internal phase emulsion (HIPE) polymerization
technique. Pore-surfaces were coated with hydroxyapatite for enhanced bio-compatibility. Rat
osteoblasts were seeded and cultured for up to 35 days to measure the cell proliferation and
formation of bone nodules (extracellular matrix with related minerals) which characterizes
functionally mature osteoblasts [88].
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1.6. Conclusion
Traditionally, bone implants made from ceramic materials have been implanted into patients. But
in recent years, polymers like poly (L-lactic acid) and poly (glycolic acid) are studied extensively
for scaffold fabrication for bone grafts. This is mainly due to their high bio-compatibility and
simple degradation by hydrolysis after implantation. Every aspect of the scaffold fabrication, from
the choice of material to the technique will impact the characteristic of the final scaffold. Currently
most of the clinical studies involving osteo-chondrogenic models overlook the aspect of
mechanical stability. Ultimate strength and compressive/tensile modulus are vital factors when
engineering a skeletal graft. Solvent-Casting and Particulate Leaching Technique is a simple
operation which gives ability to control pore size and porosity by varying the salt/polymer ratio
and particle size of the added salt. Using Gas-Foaming technique, scaffolds of high porosity and
pore size, but low connectivity can be fabricated. By electro-spinning method, large porous interconnected scaffolds can be fabricated. But the thickness is limited to microns. Three-dimensional
printing gives localized control over the micro-structure of the scaffolds. Ultimately, the tissue of
interest dictates the characteristics required of a scaffold. More clinical studies are needed to
further evaluate the potential of polymer-ceramic models or as a viable bone graft. In the case of
grafts engineered towards a musculoskeletal incorporation, mechanical stability of the graft is of
vital importance. It should be noted that few studies from the osteo-chondrogenic models have
focused on the mechanical stability, strength and stiffness of the engineered constructs. Tissue
engineering is a rapidly growing field with the use of bio-degradable synthetic polymer and their
compounds becoming increasingly feasible in vivo studies. This is further supported by the influx
of progenitor cells and access to them. In the case of human beings, adipose derived stem cells are
relatively easy to avail, and they are known for their pluripotency. Extensive in vitro as well as in
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vivo studies have been done on hASCs being differentiated into osteoblasts and implanted into
live mammals (rats, rabbits, etc.,). In scaffold assisted bone tissue engineering thorough
investigation and characterization of the scaffold to be used for cell culture is a necessity. This
study is dedicated to characterizing a three-dimensional porous PLLA scaffold combined with
hASCs as a viable bone graft model.
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Chapter 2 : Controlling the Cooling Rates of PLLA : Dioxane
2.1. Introduction
Several methods have been reported to fabricate scaffolds using synthetic biodegradable polymers.
Thermally induced phase separation method uses thermal energy and latent heat of the solvent to
induce crystallization resulting in the phase separation of the polymer [93-96]. The key advantage
in using this technique is that the micro-structural properties of the resulting scaffold can be
adjusted depending on the thermal profile imposed on the polymer/solvent solution during the
phase separation process. A large portion of research in adjusting these thermal profiles has been
focused on the quenching temperature or the final temperature of these solution or the total time
the solution was left exposed to these temperatures before the lyophilization process [86, 92, 97,
98] and Poly (l-lactic acid) (PLLA) or any of its isomers were the choice of synthetic material in
most of these works [99-101]. The main scope of this chapter was to study the cause and effect of
various temperature profiles on the micro and macro structural property of the subsequent
scaffolds. Utilizing the thermal conductivity difference of varying materials (copper = 401 W/m/K,
aluminum = 237 W/m/K and glass = 1.2 W/m/K), an attempt to induce phase separation at different
cooling rates on polymer/solvent solution was made. In situ temperature gradient of the
polymer/solvent solution was recorded and their effect on the resulting scaffolds are reported.
2.2. Materials and Methods
PLLA (mol. wt. 100,000; density 1.2 g/cc) was obtained from SurModics Pharmaceuticals
(Birmingham, AL) with trade name 100 L 7A.
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2.2.1. Fabrication of Copper and Aluminum vials
Copper and Aluminum vials of inner diameter 13.5mm and outer diameter 15.5mm were
manufactured in ME Machine Shop in Louisiana State University, Baton Rouge, LA. The total
length was 44 mm. This was done to maintain standard wall dimensions of the metal vials to that
of the commercially purchased borosilicate glass vials (Kimble® 60831D-1544 Titeseal®).
However, the dimensions of the bottom portion of the both the metal vials had to be changed as
shown in Fig. 2.2 due to lack of better manufacturing process in Me Machine Shop, LSU.

Figure 2.1. Manufactured aluminum (left) and copper (right) vials

2.2.2. Preparation of PLLA-Dioxane Solution
The PLLA-Dioxane solution was formed by dissolving 7 % wt/vol of PLLA in anhydrous 1,4Dioxane (Sigma, USA) at 323 K with constant stirring for 2 hours to form a clear solution. This
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solution was transferred into cylindrical vials (borosilicate glass or aluminum or copper) of internal
diameter 13.5 mm, keeping the volumes consistently at 5 mL. These solutions were stored at room
temperature for 48 hrs before the phase separation process.

Figure 2.2. Bottom plug of the copper vial (similar to the aluminum vial)

2.2.3. Design of the Floating Block using Expanded Polystyrene (EPS)
A cooling block to hold the aluminum, copper and glass vials was shaped using EPS. This block
directly floats above the liquid nitrogen in an EPS vessel while the solution in the vials undergo
phase separation during the controlled cooling process. The design of this block as shown in Fig.
2.3, facilitated maintaining the bottom surface of the vials at a constant height of 38 mm directly
above liquid nitrogen (-160°C). This ensured the only variables controlling the imposed thermal
profiles was the thermal conductivity of the material of the vial.
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Figure 2.3. Isometric views showing (A) top surface and (B) bottom surface of the floating
block

2.2.4. Controlled Phase Separation Process
The vials with 4 mL or 5 mL 7% (wt/vol) PLLA : Dioxane solution was placed on the floating
block and allowed to float on the liquid nitrogen surface to undergo cooling, nucleation of 1,4dioxane causing phase separation of PLLA. The in situ temperature profile of the solution was
recorded simultaneously using a type K thermocouple (Omega, CT, USA) connected to a data
logger (Vaisala Veriteq SP - 1700 - 51 W), every 10 seconds for 90 mins.
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Figure 2.4. Data logger used to measure and record instantaneous temperature during phase
separation process

2.2.5. Lyophilization Process
The frozen PLLA-Dioxane solution in the vials were transferred to a Labconco Fast-Freeze Flask.
The Fast-Freeze Flask was connected to the FreeZone Plus 2.5 Liter Cascade Console Freeze Dryer
(Labconco Corporation Kansas City, Missouri, USA) for 48 hours to sublimate the solvent
(Dioxane or Dioxane-Ethanol). The console freeze dryer maintained the frozen PLLADioxane/Ethanol vials at 0.037 bar and -55°C to generate 3D porous PLLA scaffolds. The frozen
and freeze-dried porous scaffolds were extracted from the vials and typically range in size from
15 to 16 mm in height and approximately 12 mm in diameter (somewhat smaller than the internal
diameter of the cylindrical capsule due to shrinkage during the sublimation process).
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2.2.6. Micro-structural Characterization
The cross-sectional microstructure of the frozen and freeze-dried porous scaffolds was analyzed
using Scanning Electron Microscopy (SEM) at a distance of 5 - 10 mm from the bottom scaffold
surface. Additionally, the microstructures of the frozen and freeze-dried porous scaffolds were
also obtained along the vertical cross sections. The surfaces of the 3D porous scaffolds to be
characterized were coated with 15 nm’s of Platinum using EMXS550X Sputter Coater (Electron
Microscopy Sciences, Industry Road, Hatfield, PA, USA). JEOL JSM-6610LV Scanning Electron
Microscope (Jeol, Dearborn Rd, Peabody, MA, USA) was then used to scan and capture the
scaffold micro-structural images.
2.2.7. Pore Diameter and Porosity
Pore-sizes were measured at various random locations (~20) from the SEM images using JEOL
JSM-6610LV software. Porosity of the scaffold was calculated by gravimetric method as follows
[102]:
𝑆𝑐𝑎𝑓𝑓𝑜𝑙𝑑 𝑑𝑒𝑛𝑠𝑖𝑡𝑦 (𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑 ) =

𝑃𝑜𝑟𝑜𝑠𝑖𝑡𝑦 (%) = [1 −

𝑚𝑎𝑠𝑠
𝑣𝑜𝑙𝑢𝑚𝑒

𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑
] ×100
𝑃𝐿𝐿𝐴

2.3. Results and Discussion
2.3.1. Temperature profiles
Instantaneous in situ temperatures (°C) were plotted relative to time (mins) for aluminum, copper
and glass vials. After 90 mins of cooling, the samples in coper, aluminum and glass vials cooled
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to about -25°C, -30°C and -80°C respectively. Standard deviations are plotted for replicate samples
(n = 4). Temperatures become momentarily steady at the freezing point of anhydrous 1,4-dioxane
(4 mL) around 10°C during cooling process. The average cooling rate of glass vial was the highest
at 1 °C/min. However, the average cooling rates of PLLA/dioxane copper and aluminum vials was
almost equal (copper at 0.41°C/min; aluminum at 0.48°C/min). This was contradictory to the
expected results since copper has the highest thermal conductivity of the tested materials.

Figure 2.5. Temperature profile of PLLA/dioxane in aluminum vial with standard deviations (n
= 4)
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Figure 2.6. Temperature profile of PLLA/dioxane in copper vial with standard deviations (n = 4)

Figure 2.7. Temperature profile of PLLA/dioxane in glass vial with standard deviations (n = 4)
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Figure 2.8. Comparison of mean temperature profiles of PLLA/dioxane in vials of all materials
studied

The discrepancy in the resulting cooling rates could be due to the structure of the vial itself
affecting the imposed thermal profile. At such high temperature differences, minor factors like
rubber seal (as seen in Fig2.2) in the bottom plug could be influencing the resulting cooling rates.

2.3.2. Porosity (%)
The resulting scaffolds from aluminum vials had the highest mean porosity of 90.255%. Scaffolds
from copper and glass vials had a mean porosity of 90.15% and 89.77% respectively. However,
none of these values were significantly different from each other with p-values of 0.68, 0.27 and
0.14 between Al-Cu, Cu-glass and glass-Al respectively.
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Figure 2.9. Porosity (%) of scaffolds made from Al, Cu and glass vials

2.3.4. SEM Images and Pore Sizes
The SEM image of scaffolds from copper vials showed that the pores were largely spherical shaped
and compartmentalized in the central are of the scaffold (Fig. 2.11). Visually, no sign of porous
interconnectivity was observed. However, there were long striated, spindle shaped pore structures
near the outer periphery of the scaffold. The micro-structural image of scaffold made using
aluminum vial also showed a similar but an emphasized trend with longitudinal porous structures
near the peripheral region and spherical compartmentalized pores in the central region (Fig. 2.10).
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Figure 2.10. SEM image of scaffold made from aluminum vials representing the cross-section
perpendicular to the axis (A, B) and vertical section parallel to the axis (C, D)

Micro-porous structures of scaffolds made from aluminum vials were very elongated spindle
shaped. Though the length of the pores were larger than 200 µm, the width of the pores were
approximately 10 - 20 µm. Since the average size of a human adipose stem cell is about 10 µm,
such constricted longitudinal pores may not be an ideal structural property for cell growth.

34

Figure 2.11. SEM image of scaffolds made from copper vials representing the cross-section
perpendicular to the axis (A, B) and vertical section parallel to the axis (C, D)

Scaffolds made from copper vials exhibited a homogenous distribution of spherical porous
structures on both horizontal and vertical sections. Some longitudinal porous structures were found
in proximity to the walls of the capsules i.e., in the outer peripheral region of the scaffolds.
Spherical shaped pores over a large central region may indicate poor interconnectivity of pores.
Scaffolds made from glass vials on the other hand had patterns of regular spindle shaped porous
structures alternating in all directions on the horizontal section. The vertical section shows a pattern
of porous structures propagating inside from the outer periphery as shown in Fig 2.12 (C, D).
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However, near the center, the pore structures propagate in a vertical direction, tilting towards the
walls of the glass capsules. This suggests that there is unidirectional cooling only in the central
region of the scaffold and the cooling from the walls play a major role near the outer periphery.
The scaffolds made from glass vials showed very little presence of spherical compartmentalized
pores. Therefore, scaffolds made from glass vials suggests having more interconnectivity among
porous structures.

Figure 2.12. SEM image of scaffolds made from glass vials representing the cross-section
perpendicular to the axis (A, B) and vertical section parallel to the axis (C, D)
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Figure 2.13. Comparison of mean pore-sizes of scaffolds made from Al, Cu and glass

Pore-sizes were measured from the SEM images on both vertical and horizontal sections. For
spherical pore shapes pore-sizes were measured at random direction. For spindle shaped pore
structures, the lengths of the pores were measured as this would influence the connectivity and
resulting cell growth in that cavity. The mean pore-size of scaffolds made from aluminum vials
had the highest of 279.91 µm. Scaffolds made from glass and copper had a mean pore-size of
228.78 µm and 120.04 µm respectively. However, there was no significant difference between the
pore-sizes of scaffolds from aluminum and glass vials. Standard deviations of all samples were
relatively large due to irregularity of porous structures which is expected from any non-3D printed
fabrication method.
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2.3.5. Compression Testing
Cylindrical samples of 12 mm in diameter and 10 mm in height were cut from the bottom of the
resulting scaffold after lyophilization process. These samples were compressed to ~ 90% of its
original height in the axial direction using INSTRON 5900 Series – Advanced Mechanical Testing
Systems Compression tester (Instron Industrial Products, Liberty Street, Grove City, PA, USA).
Compression was programmed at a rate of 0.9 mm/min while instantaneously measuring the force
applied (N) and real strain values. The axial stresses calculated from the force applied and crosssectional area (the cross-sectional area remained the same before and after compression) are
plotted with respect to the strain experienced by the scaffolds in Fig. 2.14. The compressive
modulus was calculated by linear regression method and plotted in Fig 2.15.
In Fig. 2.14, scaffolds made from copper and aluminum vials shows similar stress-strain curves
relative to scaffolds made from glass vials. The scaffolds made from glass vials has a higher
compression modulus of 806 kPa compared to scaffolds made from copper and aluminum vials
(481 kPa and 437 kPa respectively). The compressive strength of copper and aluminum varied
largely among replicate samples primarily because of the inconsistent height of the vials above
liquid nitrogen over the cooling time of 90 mins. Compressive modulus of aluminum and glass
showed a statistical significance of p = 0.01 while other pairs of data were statistically
insignificant. From Fig. 2.15, the imposed cooling rate could have an influence on the compressive
modulus of the resulting scaffolds since the scaffolds made from glass vials with a cooling rate of
1.44°C/min has a higher compressive modulus of scaffolds made from copper and aluminum vials
(0.4°C/min).

38

Compressive Stress (kPa)

4000
Copper
Aluminum
Glass

3500
3000
2500
2000
1500
1000
500
0
0

0.2

0.4
0.6
Compressive Strain

0.8

1

Figure 2.14. Compressive stress vs strain of scaffolds made from copper, aluminum and glass
vials (n = 7)

Figure 2.15. Compressive modulus of scaffolds made from copper, aluminum and glass vials (n
= 7)
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2.3.6. Effect of Initial Concentrations of PLLA on Structural Properties of Scaffolds
Glass vials were found to be ideal to impose a high cooling rate and to reach lower temperatures
at the end of the freezing process. The effect of initial concentration of PLLA in dioxane on the
structural properties were studied by repeating the freezing process using three different
concentrations of 3, 5 and 7% (wt/v). For this study, 5 mL of solutions were used in every vial.
This allows to have a thicker scaffold and to visualize the micro-porous structure above 10 mm
from the bottom. Fig. 2.16 shows the cooling profile of the solutions with their maximum
variations marked as error bars. It can be observed that the temperature profiles overlap each other
and no significant trend is observed with increasing initial concentrations of PLLA in dioxane.

Figure 2.16. Temperature profile of PLLA/dioxane solutions at various concentrations with
maximum temperature variations (n = 3)
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The cooling rate of each of the solution concentrations from its nucleation point (10°C) to its final
temperature was calculated and plotted in Fig 2.17. Highest effective cooling rate of 1.99°C/min
was observed in 3% PLLA/dioxane. When 5% and 7% concentrations were used, the effective
cooling rates were 1.19 and 1.45°C/min respectively. No significant change in cooling rates were
observed between 3 and 7% concentrations. Effective cooling rates of 5 and 7% samples were also
statistically insignificant with a p - value of 0.13. Thus, it can be concluded that the concentration
of PLLA in dioxane does not play a significant role in deciding the in situ cooling rate of the
solution.

Figure 2.17. Cooling rates of the solution with increasing concentrations of PLLA
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Figure 2.18. SEM image of scaffolds made from 3% (wt/v) PLLA/dioxane representing the
cross-section perpendicular to the axis (A, B) and vertical section parallel to the axis (C, D)

Scaffolds made from 3% PLLA in dioxane were comprised of relatively irregular porous patterns
in the central region. However, near the surface touching the vials while cooling, the porous
structures were radially inward. This may be caused by relatively higher cooling rates of
1.99°C/min experienced by these scaffolds. The vertical sections show porous structures in the
axial direction slightly tilting towards the periphery. These patterns were very similar to the
scaffold micro-structure from 4mL of 7% (wt/v) solution in glass vials.
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Figure 2.19. SEM image of scaffolds made from 5% (wt/v) PLLA/dioxane representing the
cross-section perpendicular to the axis (A, B) and vertical section parallel to the axis (C, D)

The scaffolds made from 5% PLLA in dioxane had more regular porous patterns compared to the
3% samples. The extent of radial porous structures from the periphery were longer as observed in
Fig 2.19 (C, D). This potentially increases the interconnectivity of pores and also the mean poresize. The comparatively lower cooling rate did not cause any major changes in the pore structures
generally observed.
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Figure 2.20. SEM image of scaffolds made from 5% (wt/v) PLLA/dioxane representing the
cross-section perpendicular to the axis (A, B) and vertical section parallel to the axis (C, D)

When the initial PLLA concentration was increased to 7% (wt/v), the porous patterns were very
similar to previously observed. However, the length of the radial pores increased a lot as observed
in Fig 2.20 (B, D). The pore-sizes were measured using the JEOL JSM software. The mean-poresize and their standard deviations are marked in Fig 2.21. The 7% (wt/v) PLLA/dioxane scaffolds
had the highest mean pore-size of 212.6 µm. At the concentration of 3 and 5% (wt/v) PLLA in
dioxane, the mean pore-sizes were 92.01 µm and 114.55µm respectively. However, there was no
statistical significance between 3 and 5% concentrations.
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Figure 2.21. Mean pore-size of scaffolds with increasing concentrations of PLLA (n ~ 10)

Figure 2.22. Real time stress strain curves of scaffolds made from 3, 5 and 7% (wt/v) PLLA in
dioxane (n = 3)
45

From the instantaneous stress-strain values (Fig 2.22), using linear regression method,
compressive modulus for each scaffold made from varying initial concentrations of PLLA was
calculated and plotted in Fig 2.23. The compressive modulus were 273.07 kPa, 860.63 kPa and
1475.14 kPa for 3, 5 and 7% (wt/v) of initial concentrations respectively. Thus, there is a
significant increase of compression strength when PLLA concentration was increased. However,
the influence of imposed thermal profile (cooling rate) on the mechanical integrity of the resulting
scaffolds is unknown as there was no control over the imposed cooling rate.

Figure 2.23. Compressive moduli of scaffolds made from 3, 5 and 7% (wt/v) PLLA in dioxane
(n = 3)
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2.3.7. Cooling Rate of Copper, Aluminum and Glass Vials in Dry Ice Bath
Throughout the ‘effect of initial concentrations of PLLA’ study, the cooling rate was uncontrolled
and was in part determined by the EPS floating block’s structure and the thermal property of the
glass. The highest cooling rates ever achieved by above experiments was 1.99°C/min. Since
quenching in liquid nitrogen (-196°C) was not a practical option as it broke the glass vials
completely, dry ice bath (dry ice and ethanol) was used as a quenching medium. Copper, aluminum
and glass vials were filled with 4 mL of 7% (wt/v) PLLA/dioxane solution. These vials were
directly quenched in dry ice bath while simultaneously measuring the temperature. The cooling
profiles are shown in Fig 2.24.

Figure 2.24. Temperature profile of 7% (wt/v) PLLA/dioxane solution in aluminum, copper and
glass vials immersed in dry ice bath (-80°C)
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The lowest temperature of -70°C was reached within 3 - 4 mins of immersion. The effective
cooling rates from nucleation temperature to -70°C was calculated to be 34.67, 31.60 and
21.02°C/min for copper, aluminum and glass respectively. Though the cooling rates were higher
by quenching in a liquid bath, all the vials had almost similar cooling rates. Therefore, quenching
is not an ideal method to achieve a controlled cooling rate.
2.4. Conclusion
The experimental thermal profile of PLLA/dioxane in copper and aluminum vials were unexpected
as the thermal conductivity of both the metals are significantly higher than glass. Though the
structural difference in the metal vials could have played a role in limiting the thermal conduction
of liquid nitrogen vapors, there could be an error in reading the temperature in situ. Galvanic
corrosion between the thermocouple and metal vials could be possibility considering the presence
of 1,4-dioxane in the solution. Also, glass vials were able to provide the lowest temperature at the
end of 90 mins exposure to liquid nitrogen vapors. Copper and aluminum vials provided a
minimum temperature of - 25°C and -30°C respectively, which is too high compared to the liquid
nitrogen vapors at -160°C. The compressive modulus of scaffolds made from glass were
significantly higher than that of scaffolds made from aluminum. Since mechanical integrity of a
bone graft is of primal importance, though aluminum and glass vials provided a high mean poresize with no significant difference, in future glass vials will be used to make scaffolds with
equipment assisted imposition of varying thermal profiles.
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Chapter 3 : Characterization of Scaffolds Made from Control Rate Freezer (CRF)
3.1. Introduction
There are many methods which have been used to fabricate 3D porous scaffolds of synthetic
polymers, including solvent casting/particulate leeching techniques, gas-foaming process, electrospinning method, and thermally induced phase separation (TIPS). The advantages of solvent
casting method include: simple operation, ability to control pore size and porosity by varying the
salt/polymer ratio and particle size of the added salt [38, 103, 104]. However, the scaffolds do not
exhibit sufficient mechanical strength and the required material properties.33 Gas foaming allows
the forming of 3D porous polymer structures with very high porosities (~90%) and pore sizes
(~100 µm), however, the interconnectivity of pores is low, limiting the permeations of nutrients
and cells into the scaffold matrix [39, 105, 106]. Electrospinning allows localized control on the
micro-structure of the porous scaffold but is highly unsuitable and cumbersome to fabricate thick
(mm size) 3D scaffolds [40, 107, 108]. TIPS is a simple procedure in which, the polymer dissolved
in a solvent is frozen, subsequently the solvent is sublimated, resulting in a porous scaffold. The
scaffolds fabricated using TIPS exhibit a compression moduli ~20 times higher than that of the
scaffolds fabricated using other methods [41], while generating scaffolds with a pore size of 30–
150 µm [93, 109, 110]. The pore morphology of the scaffolds varies depending on the
concentration of the polymer solution as well as the induced thermal profile during freezing
process. The objective of this study was to characterize the 3D porous Poly (l-lactic acid) (PLLA)
scaffolds made in varying concentrations (3, 7 and 10% wt/vol) of PLLA in dioxane using three
different freezing rates (1, 10 and 40°C/min to a final temperature of −60˚C). PLLA was chosen
as the scaffold material due to its bio-compatibility and slower rate of degradation in vivo when
compared to PLGA [99]. Furthermore, PLLA is FDA approved for in vivo research and has proven
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to show more osteogenic properties than some ceramics. The fabricated scaffolds were analyzed
to determine the structure-property relationship as a function of the polymer concentration and the
imposed cooling rate.
3.2. Materials and Methods
3.2.1. Preparation of PLLA-dioxane/ethanol Solutions
PLLA (Mn: 100,000; density: 1.2 g/cm3) was obtained from SurModics Pharmaceuticals
(Birmingham, AL) with trade name ‘100 L 7A’. The PLLA-Dioxane solution was formed by
dissolving 3, 7 and 10 % weight of PLLA in dehydrated 1,4-Dioxane solution or in 85% dioxane
with 15% ethanol solution. The concentration Ethanol was limited to a maximum of 15% as that
was the cloud-point concentration at room temperature. The mixture at 50 ˚C was stirred with a
magnetic stirrer until a clear solution is formed. Approximately 5 mL of the PLLA-Dioxane
solutions were transferred into cylindrical capsules of (internal) diameter of 13mm and stored at
room temperature (27 to 30 ˚C).
3.2.2. Freezing process using Control Rate Freezer (CRF)
The cylindrical capsules (or vials) filled with PLLA/dioxane (: ethanol) solution were placed in
the cooling chamber of a CRF (Planer PLC Group, Shepperton Surrey TW16 7HD, UK). The CRF
was connected to a liquid nitrogen supply at 22 psi. The thermal profile of the chamber was
programmed in the controller of the CRF as follows: Step (i): Cool from 20˚C to 10˚C at 10˚C/min;
Step (ii): Hold at 10˚C for 1 min to nucleate 1,4 Dioxane (initial characterization experiments
showed the phase change temperature of 1,4-Dioxane in PLLA to be ~10˚C); Step (iii): Cool from
10˚C to −60˚C at the pre-determined rate of cooling of either 1, 10 or 40 ˚C/min. The accuracy of
the CRF was verified by measuring the temperature in the well plates, using type-T hypodermic
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needle thermocouples (Omega Technologies, Stamford, CT, USA). Thermocouple voltages were
read by a precision temperature data logger (Veriteq Instruments Inc, Richmond, BC, Canada) and
transferred to a personal computer for further reduction and data analysis. The cooling rates
imposed by the CRF was within 5% for cooling rates of ≤10 ˚C/min and within 10% for the highest
cooling rates of 40 ˚C/min.
3.2.3. Freeze-drying Process
The frozen PLLA/dioxane (: ethanol) vials were immediately transferred to an ice pack (4°C) for
transportation to the freeze dryer location (5mins) were the samples were placed in Labconco FastFreeze Flask. The Fast-Freeze Flask was connected to the FreeZone Plus 2.5 Liter Cascade
Console Freeze Dryer (Labconco Corporation Kansas City, Missouri, USA) for 48 hours to
sublimate the solvent (Dioxane or Dioxane-Ethanol). The console freeze dryer maintained the
frozen PLLA-Dioxane/Ethanol vials at 0.037 bar and -55°C to generate 3D porous PLLA
scaffolds. The frozen and freeze-dried porous scaffolds were extracted from the vials and typically
range in size from 15 to 16 mm in height and approximately 12 mm in diameter (somewhat smaller
than the internal diameter of the cylindrical capsule due to shrinkage during the sublimation
process).
3.2.4. Compression Testing
INSTRON 5900 Series – Advanced Mechanical Testing Systems Compression tester (Instron
Industrial Products, Liberty Street, Grove City, PA, USA) was used to compress the 3D porous
PLLA scaffolds that were trimmed to 10 mm in length using a VWR razor blade. The cylindrical
3D porous scaffold samples (12 mm in diameter and 10 mm in length) were loaded onto the center
of the compression anvil and the two jaws of the tester were adjusted to be in contact with the top
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and bottom of the scaffold. The compression machine was programmed to compress the 3D porous
PLLA scaffolds to 20% of its original length in the axial direction and to 66.67% of its original
length in the radial direction, while simultaneously recording the instantaneous load applied (Fi)
and the compressive strain (ϵi) experienced by the sample. From the instantaneous loads at each
time point, compressive stress was calculated from which the Compressive Moduli was calculated
as follows:

𝐼𝑛𝑠𝑡𝑎𝑛𝑡𝑎𝑛𝑒𝑜𝑢𝑠 𝑆𝑡𝑟𝑒𝑠𝑠 (𝜎𝑖 ) =

𝐼𝑛𝑠𝑡𝑎𝑛𝑡𝑎𝑛𝑒𝑜𝑢𝑠 𝐿𝑜𝑎𝑑 𝐴𝑝𝑝𝑙𝑖𝑒𝑑 (𝐹𝑖 )
𝐶𝑟𝑜𝑠𝑠 − 𝑠𝑒𝑐𝑡𝑖𝑜𝑛𝑎𝑙 𝑎𝑟𝑒𝑎 𝑜𝑓 𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑

𝐶𝑜𝑚𝑝𝑟𝑒𝑠𝑠𝑖𝑣𝑒 𝑀𝑜𝑑𝑢𝑙𝑢𝑠 =

∑(𝜖𝑖 − 𝜖̅) ∙ (𝜎𝑖 − 𝜎̅)
∑(𝜖𝑖 − 𝜖̅)2

3.2.5. Micro-structural Characterization
The cross-sectional microstructure of the frozen and freeze-dried porous scaffolds was analyzed
using Scanning Electron Microscopy (SEM) at a distance of 5 mm from the bottom scaffold
surface. Additionally, the microstructures of the frozen and freeze-dried porous scaffolds were
also obtained along the vertical cross sections. The surfaces of the 3D porous scaffolds to be
characterized were coated with 15 nm’s of Platinum using EMXS550X Sputter Coater (Electron
Microscopy Sciences, Industry Road, Hatfield, PA, USA). JEOL JSM-6610LV Scanning Electron
Microscope (Jeol, Dearborn Rd, Peabody, MA, USA) was then used to scan and capture the
scaffold micro-structural images.
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3.2.6. Pore Diameter and Porosity
Pore-sizes were measured at various random locations (~20) from the SEM images using JEOL
JSM-6610LV software. Known volume of scaffolds (5 mm in height and 12 mm in diameter;
0.5655 cm3) were weighted to obtain the density of scaffold (𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑 ). The density of pure PLLA
is known as 1.25 g/cm3. Porosity of the scaffold was calculated by gravimetric method as follows
[102]:
𝑆𝑐𝑎𝑓𝑓𝑜𝑙𝑑 𝑑𝑒𝑛𝑠𝑖𝑡𝑦 (𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑 ) =

𝑃𝑜𝑟𝑜𝑠𝑖𝑡𝑦 (%) = [1 −

𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑
𝑃𝐿𝐿𝐴

𝑚𝑎𝑠𝑠
𝑣𝑜𝑙𝑢𝑚𝑒

] ×100

3.2.7. Inter-connectivity of pores
Cylindrical scaffolds of 10 mm in height were fixed to the bottom of a 50 mL Pyrex® graduated
measuring cylinder (Sigma-Aldrich, USA) using 1% agarose gel. This step was done to neglect
the effects of buoyant forces when the measuring cylinder was filled with 100% ethanol up to 50
mL mark. The scaffolds were allowed to soak the 100% ethanol for 1 hour. Ethanol was used as a
soaking medium, since PLLA is hydrophobic in nature with a water contact angle of higher than
120°. After an hour, the drop in the volume of ethanol was measured by refilling ethanol to reach
the closest 50 mL mark using a combination of 100 and 1000 µL Eppendorf® Reference® 2
Variable Volume Pipettors (Sigma-Aldrich, USA). This excess volume absorbed by the scaffolds
gives a measure of interconnected porous volume as isolated, closed pores will not absorb any
ethanol. The interconnected region within a 10 mm height scaffold construct was expressed as
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percentage by calculating the ratio of interconnected porous volume within a scaffold to the toal
volume of the scaffold (1.13 cm3).
3.3. Results and discussion
In Fig.3.1 micro-porous structure of scaffolds made from PLLA dissolved in 100% dioxane is
shown according to the percentage of PLLA used and cooling rate imposed.
The porous structures looked more spherical in scaffolds made from 3% PLLA especially at
cooling rates 1 and 10°C/min. No significant change in morphology was found between vertical
and cross-sections at this PLLA concentration. Scaffolds made from 7 and 10% PLLA showed
spindle-shaped pore structures. In general, the micro-porous structures became more regular with
increase in cooling rates and proportion of PLLA used. However, in the case of 3% PLLA, porous
structures were irregular even with increased cooling rates. With increasing concentrations of
PLLA the pores were highly compartmentalized suggesting relatively poor interconnectivity.
Both macro-pores (>50 μm) and micro-pores (10-50 μm) were found in scaffolds made using 10%
PLLA for all cooling rates. Combinations of pore-sizes in these ranges have reported to show better
cell proliferation, vascularization and bone formation in vivo for ceramic scaffolds [111]. Though
it was impossible to achieve a localized control on the micro-structure of scaffolds as reported in
3D printing [112-114] or have a high degree of interconnectivity as electro-spinning technique
[40, 91, 115-117], regulating cooling thermal profile on different PLLA concentrations using TIPS
method may help to achieve the necessary micro-structure in the scaffolds.
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Figure 3.1. SEM images showing the micro-structures of the cross-section at 5 mm from the
bottom of PLLA scaffolds made by cooling at 1°C/min (a, b and c), 10°C/min (g, h and i) and
40°C/min (m, n and o). Micro-structure of the vertical section in the region 0 – 5 mm for
scaffolds cooled at 1°C/min (d, e and f), 10°C/min (j, k and l) and 40°C/min (p, q and r). All
images arranged according to increasing PLLA concentrations in dioxane from left to right
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Pore-sizes (n ~ 20) were measured at random from the SEM images and the mean pore size was
plotted along with their standard deviations in Fig.3.2. Scaffolds made from 3% PLLA showed a
decreasing trend of mean sizes such as 93.87 μm, 81.34 μm and 69.31 µm when cooled at 1, 10
and 40°C/min. However, none of these values were significantly different from each other due to
relatively high standard deviations. Scaffolds made from 7% PLLA had a mean pore size of ~ 93
μm when cooled at 1 and 40°C/min, but when cooled at 10°C/min it shows a significant decrease
to 74.05 µm. In scaffolds made from 10% PLLA, highest mean pore size of 90.42 μm was achieved
when frozen at 10°C/min. Other mean pore sizes were 66.85 and 75.24 μm when cooled at 1 and
40°C/min respectively. In the case of 7% and 10% scaffolds, the length of the spindle structured
pores were measured as the pore-size. This was done since the spindle structured hASCs were
found to grow aligning along these structures with longer culture periods as observed in 42nd day
(Chapter 4). Standard deviations of pore-sizes were found to improve with increasing PLLA
concentrations for all cooling rates. High standard deviations in 3% PLLA scaffolds suggest
irregular pore-structures as observed in SEM images.
Highest mean porosity of 96.65% was obtained in 3% PLLA scaffolds at cooling rate 1°C/min.
When 7% PLLA was used, the porosity drops to ~92% as shown in Fig. 3.3. Both 3% and 7%
scaffolds showed a very slight decrease in % porosity, linearly proportional to the logarithm (to
the base 10) of the cooling rate used. The decrease in % porosity with respect to the increasing
cooling rates was not significant (p-value > 0.05) for 3 and 7% PLLA scaffolds. In 10% scaffold,
the highest porosity (90.36%) was obtained when cooled at 10°C/min. When cooled at 1 and
40°C/min, it was 89.3% and 88.22% respectively.
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Figure 3.2. Mean pore diameter and standard deviations of scaffolds made from 3, 7 and 10
(wt/vol) % PLLA in Dioxane, measured randomly from SEM images (16-20 values per sample),
and plotted corresponding to increasing cooling rates. ** indicates not significant (p-value > 0.1)
(n ~ 20)

The red lines drawn at 97, 93 and 90% represents the theoretical porosity values of the initial
concentrations (3, 7 and 10% respectively) of PLLA. Mean porosity of scaffolds made from 3 and
7% initial concentrations of PLLA were slightly lower than the theoretical values. This could be
attributed due to the shrinkage of the PLLA/dioxane solution when cooled at higher cooling rates.
Also, the shape of scaffolds after lyophilization process was similar to a negative imprint of a right
conical structure from the top, suggesting movement of the PLLA/dioxane solution towards the
walls of cylindrical capsules during freezing process. The porosity (%) of resulting scaffolds were
calculated to determine the significance of this change of shape. However, it was found that there
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was no significant change of porosity from the theoretical values for all initial concentrations and
the change of porosity with increasing cooling rates were statistically insignificant.
Using TIPS to make 3D synthetic polymer scaffolds, high values of % porosity was achieved,
which is vital for intrinsic vascularization of bone implants in vivo [118, 119].

Figure 3.3. Percentage porosities of scaffolds made by dissolving 3, 7 and 10 (wt/vol) % PLLA
in Dioxane, measured by void fraction method and are plotted against increasing cooling rates on
a log10 scale (n = 4)

When compared to ceramic scaffolds which usually has porosity ranging 25 - 80 % [48, 49, 120,
121], our PLLA scaffolds had very high porosity (88 – 96 %) which is comparable to synthetic
polymer scaffolds made by other methods like super-critical drying, gas-foaming, salt-leeching or
a combination of these methods [122-131]. These values are closer to the 90% porosity of a
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cancellous bone in human adult skeleton [62-64]. Higher porosity values and regular distribution
of pores facilitate better degradation in vivo [132-136].

Figure 3.4. Real time axial stress strain curves of scaffolds made by dissolving (A) 3 (wt/vol) %
(B) 7 (wt/vol) % and (C) 10 (wt/vol) % PLLA in dioxane, showing increasing compressive
strength with increasing cooling rates. (D) Compressive Moduli of 3, 7 and 10 (wt/vol) %
samples plotted along increasing cooling rates on log10 scale (n = 6)

Axial stress-strain curves of 3%, 7% and 10% scaffolds in Fig. 3.4 shows increased compressive
strength with increasing cooling rates for all PLLA concentrations. The compressive modulus
calculated by linear regression method increases linearly to logarithm (to the base 10) of the
imposed cooling rate for each concentration of PLLA in solvent. Compressive moduli of 3%, 7%
59

and 10% PLLA scaffolds increased from 185.83 to 522.72 kPa, 1248.92 to 3426.29 kPa and
2989.05 to 9606.11 kPa respectively with increasing cooling rates. Also, the rate of increase in
compressive modulus with respect to the logarithm (to the base 10) of cooling rate, increases
significantly (~ 6 times from 3 to 7% PLLA and ~4 times from 7 to 10% PLLA) with increase in
PLLA concentration.
The stress values along the mid-section perpendicular to the plane of loading was calculated from
the known cross-sectional area (12 × 10 mm2). The cross-sectional area of the midsection was
measured to be same before and after the compression test. Stress-strain curves of 3% scaffolds
shows a similar trend to that of the axial direction with increasing cooling rates as shown in Fig
3.5. However, the overall compressive modulus decreased more than 100 times (185 kPa to 1.1
kPa) in the radial direction when cooled at 1°C/min, about 160 times (316 kPa to 1.97 kPa) when
cooled at 10°C/min and about 175 times (522 kPa to 2.97 kPa) when cooled at 40°C/min. The
stress-strain curves of scaffolds made from 7 and 10% PLLA in dioxane solutions showed no
change in the compressive strength with increasing cooling rates. The mean compressive modulus
of 7% scaffolds cooled at 1°C/min was 14.1 kPa and when cooled at 10 and 40°C/min the
compressive modulus was about 8.8 kPa. In the case of scaffolds made from 10% PLLA in dioxane
the compression moduli were 28.4, 23.46 and 22.02 kPa when cooled at 1, 10 and 40°C/min
respectively. However, there was no statistical significance of compressive modulus with
increasing cooling rates for 7 and 10% scaffolds. This huge difference in compressive modulus of
scaffolds between the axial and radial direction maybe influenced by the porous structures
propagating in the radial direction is shifted towards the bottom of the capsule during the cooling
process. Thus, the scaffold microstructure provides more resistance to axial loads than radial loads.
As the cooling rate increases more number of pores are formed along this shifted direction as
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observed in Fig 3.1 e, f, k, l, q and r. This combined with the porous formation in the axial direction
from the bottom of the capsules may contribute to the substantial increment of axial compressive
modulus with increasing cooling rates. Thus, the relative alignment of porous structures in the
scaffold contribute to the fate of compressive modulus with varying cooling rates in any given
direction.

Figure 3.5. Real time radial stress strain curves of scaffolds made by dissolving (A) 3 (wt/vol) %
(B) 7 (wt/vol) % and (C) 10 (wt/vol) % PLLA in dioxane, showing increasing compressive
strength with increasing cooling rates. (D) Compressive Moduli of 3, 7 and 10 along the
perpendicular mid-section to the loading direction (n = 4)
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Table 3.1. Comparison with characteristics of scaffolds made from other studies
Pore-size

Scaffold material /

Porosity (%)

Compressive
Modulus (MPa)

Fabrication method
Min

Max

Min

Max

Min

Max

30 μm

1 mm

25

80

3

50

67

97

0.15

0.3

46.8

78.4

100

1800

-

-

1.09

20

Non-3D printed
ceramic scaffolds [4749, 119-121, 137, 138]

100 μm (439
Polymers / Gas
foaming [50, 51, 106]

10 μm

μm with salt
leeching)

Ceramics / Gas

100 μm

400 μm

Polymers / Electro-

0.11 μm

1.19 μm (fiber

spinning [40, 54, 55, 107]

(fiber dia)

dia)

50 μm

100 μm

71

91

0.15

6.2

30 μm

240 μm

88.22

98.22

0.101

9.61

foaming [52, 53]

Polymers / TIPS [56, 57,
110, 139]

PLLA / TIPS (present
study)

The maximum compressive modulus of ~10MPa was achieved when 10% PLLA was dissolved in
100% dioxane and cooled at 40°C/min. This is about 100 times lower than the compressive
modulus of pure PLLA (1GPa) and about 3500 times lower than the young’s modulus of cortical
bone (35 GPa) [61, 140] and about 5 times lower than the least young’s modulus of a human
cancellous bone (50-500 MPa) [48, 61]. Considering that the % porosity (90%) [62, 63] and pore
size (~ 50 μm) [64] of a human cancellous bone is comparable to the scaffolds made from 10%
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PLLA in pure dioxane and cooled at 10 and 40°C/min. Consequently, they could be an ideal
scaffold for developing TE cancellous bone graft which could be implanted in vivo using acrylic
cement for additional mechanical strength [141, 142].
For fair comparison, 3D ceramic (Hydroxyapatite / β-tricalcium phosphate) constructs which were
fabricated using cost efficient methods like thermal extrusion, gas-foaming processes or
commercially available products are considered in Table 3.1 (modified from Table 1.2 to compare
characteristic values from present study).

Inter - connectivity (%)

100
1°C/min
10°C/min
40°C/min

95
90
85
80
75
3%

7%

10%

Figure 3.6. Volumetric percentage of inter-connected pores (n = 3)

These ceramic scaffolds have highest pore-sizes and compressive moduli, but very low % porosity.
This could hinder intrinsic vascularization and bio-degradation in vivo. In the case of polymeric
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scaffolds, comparatively high % porosities and compression moduli was obtained using TIPS
technique. No data for % porosity was available for scaffolds made using electro-spinning method.
This may be due to the inability to obtain a 3D construct using this method. In this study, by
controlling the cooling rates in TIPS technique, even higher values of % porosities and
compression moduli were achieved.
The percentage of interconnected volume varies within a tight range of 83% to 87%. No statistical
significance was observed for any pairs of data sets except between 10% initial concentration
cooled at 1 and 40°C/min, between 3% and 10% cooled at 10°C/min and between 3% and 10%
cooled at 40°C/min.

Figure 3.7. SEM images showing the porous micro-structures of PLLA scaffolds made by
cooling each of the 3, 7 and 10 (wt/vol) % PLLA in Dioxane : Ethanol (0.85 : 0.15) solution at 1,
10 and 40°C/min using Control Rate Freezer (CRF).
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In Fig 3.7 micro-porous structure of scaffolds made from PLLA dissolved in 85% dioxane and
15% ethanol is shown according to the percentage of PLLA used and cooling rate imposed. The
porous structures of all the samples were irregular when compared to Fig.1. However, pore-sizes
of scaffolds made by dissolving 7 and 10% PLLA in dioxane : ethanol (0.85 : 0.15) were larger
than 100% dioxane. When compared to PLLA in pure dioxane, the inter-connectivity of pores
seemed to increase when ethanol was used in the solvent. The anisotropic pore structures found in
scaffolds made from PLLA in 100% dioxane was absent when ethanol was used. Both vertical and
cross-sectional porous structures looked identical.

Figure 3.8. Mean pore diameter and standard deviations of 3, 7 and 10 (wt/vol) % PLLA in
Dioxane : Ethanol (0.85 : 0.15) solution measured randomly from SEM images, and plotted
corresponding to increasing cooling rates ( n ~ 20)
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Mean pore-sizes of scaffolds made using dioxane : ethanol solution showed decreasing trend with
3% PLLA and increasing trend with 7% PLLA with increasing cooling rates (Fig 3.8). Scaffolds
made from 10% PLLA gave a constant mean pore-diameter of ~135μm for 1 and 10°C/min. When
cooled at 40°C/min the pore-diameter dropped to ~120μm. Standard deviations of all the samples
were very high (~40%) suggesting irregular porous structures.

Figure 3.9. Real time axial stress strain curves of scaffolds made by dissolving (A) 3 (wt/vol) %
(B) 7 (wt/vol) % and (C) 10 (wt/vol) % PLLA in Dioxane : Ethanol (0.85 : 0.15) solution,
showing increasing compressive strength with increasing cooling rates. (D) Compressive Moduli
of 3, 7 and 10 (wt/vol) % samples plotted along increasing cooling rates on log10 scale (n = 4)
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When PLLA was dissolved in dioxane : ethanol solution, scaffolds showed decreased compression
strength (Fig. 5B) when compared to PLLA dissolved in 100% dioxane. The compressive modulus
was also decreased for all the parameters. Compressive moduli of 3%, 7% and 10% PLLA
scaffolds increased from 101.46 to 212.35 kPa, 712.57 to 2172.48 kPa and 1842.88 to 8585.32 kPa
respectively with increasing cooling rates. The structural integrity was weaker under high strains
(ɛ > 0.6) when compared to scaffolds made from PLLA in 100% dioxane solution. However, the
compressive modulus was linearly proportional to the logarithm (to the base 10) of the imposed
cooling rate for each concentration of PLLA in solvent, similar to the results of scaffold made
using pure dioxane.

Figure 3.10. Variation of compressive modulus due to increasing cooling rates of PLLA
scaffolds w.r.t. porosity (%)
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In all other methods of scaffold fabrication, compression modulus was always compromised as an
inverse function of the % porosity [48, 49, 123, 124, 128-130]. However, as stated earlier, high
values for % porosity (~ 90%) and compression modulus (~ 10 MPa) are critical to foster the use
of synthetic polymeric scaffolds. As described in this study, an analysis of the synthetic PLLA
scaffolds fabricated using successively higher cooling rates (1 to 40 ˚C/min), irrespective of the
PLLA : Dioxane concentration (ranging from 3 to 10%) resulted in the generation of scaffolds
with regular micro-structure and consequently, these scaffolds showed increasing compression
modulus while retaining a high % porosity (>88%) as shown in Fig.3.10.
3.4. Conclusion
Thermally Induced Phase Separation (TIPS) method was used to make porous three-dimensional
PLLA scaffolds. The effect of imposed thermal profile during freezing of the PLLA in dioxane
solution on the scaffold was characterized by their micro-structure, porosity (%), pore-sizes
distribution and mechanical strength. The porosity (%) decreased considerably with increasing
concentrations of PLLA in the solution, while a decreasing trend was observed with increasing
cooling rates in both types of solvents. The mechanical strength increases with increase in PLLA
concentration and also with increase in the cooling rate. Scaffolds made using higher
concentrations of PLLA in solvent, showed better mechanical strength which improved relatively
with increasing cooling rates in each case of initial PLLA concentration. This phenomenon of
enhanced structural integrity with increasing cooling rates was more prominent in scaffolds made
from higher initial PLLA concentrations. Therefore, by having a critical control over the imposed
thermal profile during the freezing process of TIPS, mechanical strength of the scaffold can be
controlled while maintaining relatively consistent (%) porosity.
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Chapter 4 : Human Adipose Derived Stem Cells (hASCs) Isolation, Loading and Culture
on PLLA Scaffolds Prepared using Thermally Controlled Methods

4.1. Introduction
Engineered tissues (grafts) a combination of scaffolds and cells could provide an alternative to
the auto- and allo-grafts described earlier. The “perfect” graft material would provide the following
properties [143, 144]: (i) Mechanical support: stabilizes the surgical site; (ii) Osteoconductive:
facilitates the ingrowth and integration of adjacent bone; (iii) Osteoinductive: recruit and stimulate
the formation and growth of bone from cells that may not naturally do so and; (iv) Osteogenic:
contain cells that themselves are capable of forming new bone. Initially synthetic calcium
phosphate (Ca-P) based hydroxyapatite (HA) was preferred as scaffold material for tissue
engineered bone grafts, due to their abundant presence in the organic bone. Ca-P when used as a
biomaterial in scaffolds also provides good osteo-conduction and bonds easily to the host bone
[118]. In another study by Will et al.,[119] porous ceramic scaffolds with higher porosity favored
rapid assimilation in vivo, while compromising on the mechanical resilience during surgery [145].
Subsequent studies explored the possibility of using biodegradable synthetic polymers like
polyglycolides (PGA) and polylactides (PLA) [146]. Both PLA and PGA degrade in vivo by
random hydrolysis of their ester bonds to form lactic acid which enters tricarboxylic acid cycle to
be excreted as water and carbon dioxide from the body. PLA-PGA copolymers used in bone repair
applications have shown to be biocompatible, non-toxic and non-inflammatory [132]. PLA/PGA
copolymer implants accelerated the osseous defects in the tibia of rats. Many studies suggest that
these polymers are sufficiently biocompatible [147]. In this study, human adipose derived stem
cells (hASCs) derived from collagenase digestion of harvested subcutaneous adipose tissue
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aspirates from liposuction procedures were used to measure and observe its response to PLLA
scaffolds prepared by thermally controlled methods.
4.2. Materials and Methods
4.2.1. PLLA Scaffold Preparation and Selection
Crystalline PLLA was dissolved in 1,4 Dioxane at 3, 7 and 10 (wt/vol) % to form a homogenous
clear solution. By thermally induced phase separation (TIPS) method, these solutions were each
frozen to a low temperature (-60°C), at 1, 10 and 40°C/min cooling rates (C.R.). The frozen
solutions were lyophilized (freeze-dried) to remove the frozen solvent resulting in the final
scaffold, which was 3D porous PLLA structure. Based on characterization data of these scaffolds
and practical handling, scaffolds made from 3 (wt/vol) % PLLA in dioxane was rejected for cell
culture experiments due to poor mechanical integrity.
4.2.2. Human Adipose Tissue Derived Adult Stem Cells (hASCs) Isolation, Collection and
Culture
All human protocols were reviewed and approved under the appropriate Louisiana State University
Institutional Review Board (#E9119) protocols. Subcutaneous adipose tissue liposuction aspirates
were provided by plastic surgeons in Baton Rouge, LA. All procedures were conducted under
aseptic conditions according to a modification of methods outlined in [148, 149]. Tissue samples
(100 to 200 ml) were washed 3-4 times in phosphate buffered saline (PBS) pre-warmed to 37 ˚C,
suspended in PBS supplemented with 1% bovine serum albumin and 0.1% collagenase (Type I,
Worthington Biochemicals, Lakewood, NJ), and digested with gentle rocking for 45-60 min at 37
˚C. The digests were centrifuged for 5 min at 1200 r/min (300Xg) at room temperature, re-
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suspended, and the centrifugation step repeated. The supernatant was aspirated and the pellet resuspended in stromal medium (DMEM high glucose, 10% fetal bovine serum, 100 IU
penicillin/mL, 100 μg streptomycin/ml, and 25 μg amphotericin/mL). The cell suspension was
plated at a density equivalent to 0.125 mL of liposuction tissue per cm2 of surface area, using a 35
mL volume of Stromal Medium per T225 flask. Cells were cultured for 48 hrs, in a 5% CO 2,
humidified, 37 ˚C incubator. At which time, the adherent cells were rinsed once with pre-warmed
PBS and the cells fed with fresh Stromal Medium. The cells were fed with fresh stromal medium
every 2-3 days until they reached approximately 75-80% confluence. The medium was then
aspirated; the cells were rinsed with pre-warmed PBS, and harvested by digestion with 0.05%
trypsin solution (5-8 mL per T225 flask) for 3 to 5 min at 37 ˚C. The cells were suspended in
stromal medium, centrifuged for 5 min at 1200 r/min (300 X g), the pellet re-suspended in a volume
of 10 mL of stromal medium, and the cell count determined by trypan blue exclusion. These cells
were identified as Passage 0 (P0) and were optimally cryopreserved [150, 151]. The stored PO
cells were thawed and passaged as described through two successive passages (P1 to P2). hASCs
from Passage 2 (P2) were used in the subsequent scaffold-cell interaction studies. Note that there
is extensive data suggesting that these adherent cells exhibit multiple lineages when culture in vitro
[152-162].
4.2.3. hASC-scaffold Loading and Culture
Based largely on the mechanical integrity and the regularity of micro-porous structures from SEM
images, scaffolds made from 7 and 10% PLLA in dioxane at all cooling rates (average pore-size
~82 μm) were chosen for cell culture. Indeed, the scaffolds made from 3% PLLA at any cooling
rate, lacked the mechanical integrity required for cell culture. These scaffolds of 12 mm in diameter
were trimmed to a height of 1 mm for DNA quantification and 2 mm for Live/Dead staining, to fit
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inside the wells of a 6 – well culture plate (Corning, USA) and affixed to the bottom of the plate
using ~250 μL of 1% Agarose gel. This setup was done to counter the hydrodynamic floating of
the scaffolds in stromal medium as PLLA is hydrophobic in nature. P2 cells were trypsinized (5
mL of 0.25% Trypsin-EDTA per T150 flask) and suspended in stromal media at a concentration
of 1.5 × 106 cells/mL. Variable amounts of hASCs in stromal medium, calibrated according to
specific assays were loaded on each scaffold’s top surface as well as in the wells without scaffolds
as control. These samples were cultured by feeding fresh stromal media (2 mL for control and ~ 6
mL for scaffold) every 2-3 days to quantify DNA and to observe the viability of hASCs on PLLA
scaffolds and control at specific time points.
4.2.4. DNA Quantification
About 1 - 2 × 105 hASCs in stromal medium were loaded on each scaffold depending on the cell
availability. For each experimental run, equal number of cells were plated on 6 - well plates as a
control. The amount of DNA was measured at specific time points to quantify the hASC
proliferation inside the scaffolds and control. The control samples and scaffolds were washed with
PBS (Gibco, USA) thrice and treated with 3 mL of lysis buffer (0.2mg/mL sodium dodecyl sulfate
(Thermo Fisher Scientific, USA) and 0.2mg/mL Proteinase K (Amresco, Ohio, USA)). The
scaffolds were homogenized in a 7 mL Dounce tissue grinder (Sigma-Aldrich, USA) to lyse all
the cells growing inside the three-dimensional construct. After incubation of 40 mins, 0.1 mL of
lysates were transferred to 96-well plate and Quant-iT™ dsDNA Assay Kit (Thermo Fisher
Scientific, USA) was used to calibrate and quantify the DNA according to the manufacturer’s
protocol.
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Figure 4.1. Perkin Elmer Wallac Victor 2 V Multi-label Counter 1420

4.2.5. Viability of hASCs
About 2 × 105 hASCs were loaded on each scaffold in stromal medium, while plating equal number
of cells in 6 - well plate as a control. The samples were washed with PBS before incubating with
Live/Dead staining solution (2 µM calcein AM and 4 µM ethidium homodimer-1) for 20 mins at
37°C to analyze the viability of hASCs on both scaffolds and culture plates. Cell-permeant, nonfluorescent calcein AM undergoes an enzymatic conversion to fluorescent calcein (Ex/Em: 495
nm/ 515 nm) in the presence of esterase activity in live cells. Ethidium homodimer-1 (EthD-1)
(Ex/Em : 528 nm/ 617 nm) undergoes a 40-fold fluorescence enhancement when it binds with
nucleic acids. Intact cell membranes of live cells prevent the entry of EthD-1. The images were
captured using SteREO Lumar.V12 (Zeiss) fluorescent microscope. The green (live) pixels and
red (dead) pixels were counted from each image after setting the threshold at the maximum
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intensity (for red and green) in each image using ImageJ program. The % viability was calculated
as the % of green pixels in total fluoresced pixels (green and red).
4.2.6. Three-dimensional Growth of hASCs in the Scaffolds
Human adipose stem cells were loaded at a concentration of 1 × 106 cells per sample and cultured
in stromal medium. After specific time points of culturing hASCs and PLLA scaffold composites
in the 6 - well plates, the samples were washed with PBS (Gibco, USA) thrice before incubating
with 0.5 % (wt/v) osminum tetroxide solution (in PBS) for 12 hours. Osmium tetroxide is used as
a fixing agent as well as a lipid stain in this process, where cell membranes are specifically stained.
After 12 hours of incubation, the samples were washed with 6 mL of DI water 5 - 6 times. The
stained, wet samples were air-dried for 2 - 3 days at room temperature. These samples were
scanned using SKYSCAN 1074 Portable X-ray Microtomograph (Bruker, NJ, USA) equipped
with a 50 kV X-ray source, in Radioisotope Imaging Laboratory (Physics Department, Louisiana
State University). The heavy metal osmium, embedded on cells, create a contrast in X-ray
scanning. The exposure time was calibrated to an ideal value of 480 ms for hASC - PLLA scaffold
composites. X-ray images were scanned parallel to the axial plane at a rate of 400 scans per 360°
rotation of the sample. The resolution of the scans were 37 µm and the device provides a filed view
of 3 cm. These 400 scans were used to reconstruct an image set of horizontal sections (~160
images) using NRecon software (Bruker, NJ, USA). The NRecon software can be used to filter
PLLA scaffold and osmium stained cellular regions due to their huge density difference. The
Hounsfield Unit (HU) of PLLA scaffold varied from -850 HU to -600 HU, while the osmium
varied from 1020 HU to 2660 HU. Thus, the two image sets were used to reconstruct a three-
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dimensional image and scaffold and cellular regions were super-imposed using NIH ImageJ
software.

Figure 4.2. SKYSCAN 1074 Portable X-ray Microtomograph

Statistical Analysis. All values are indicated as mean ± SD. Two-tailed student’s t-test was
employed, with p ≤ 0.05 considered to be statistically significant.
4.3. Results and Discussion
In Fig.4.1, quantity of DNA (ng) measured at time points 7, 14 and 21 days were normalized to
the quantity of DNA at day 1 to avoid discrepancy in cellular attachment at this time point. Fold
increase of DNA representing cell proliferation showed increased cell growth in all scaffolds
compared to the control ( 1.55 fold) at 14 and 21 days. DNA growth of control remained constant
at ~1.5 fold since it reached confluency at day 7. Mean fold increase of DNA for 7 and 10% PLLA
scaffolds shows a similar trend as the mean pore sizes in Fig. 2. DNA increased to ~ 10.5 fold in
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scaffolds made from 7% PLLA cooled at 1°C/min and 10% PLLA cooled at 10°C/min with no
statistical significance (p-value = 0.29). Similarly, scaffolds made from 7% PLLA cooled at
40°C/min, 10% PLLA cooled at 1 and 40°C/min showed a DNA increase of ~ 7.75 fold with no
statistical significance (p-value ~ 0.70) among any pair. There was weak statistical significance
between two pairs of scaffolds: 7% PLLA cooled at 1 and 40°C/min with the DNA fold growth
values at 10.03 and 8.01 respectively (p-value = 0.061); and between 7% PLLA cooled at 1°C/min
and 10% PLLA cooled at 40°C/min (7.75 fold DNA) (p-value = 0.075). Interestingly, scaffolds
made from 7% PLLA cooled at 10°C/min had the least cell growth with 5.28 fold DNA increase
at day 21. Indeed, this scaffold had the least rate of growth (using data from day 7 and 14) with
0.25 fold DNA increase per day. The highest rate of cellular growth was recorded by 10% PLLA
scaffold cooled at 10°C/min with 0.68 fold DNA increase per day. The % porosity of scaffolds
does not seem to influence the cell growth in the scaffolds as both 7% and 10% PLLA scaffolds
shows high DNA content for scaffolds that has a mean pore-size > 90 µm. The total DNA quantity
representing the cellular growth on 10% PLLA : dioxane scaffolds shows a similar pattern to its
mean pore-size with increasing cooling rates. When cooled at 10°C/min, the mean pore size was
highest at 90 µm, whereas the other two cooling rates had a comparatively lower mean pore size
of ~ 70 µm. Almost, 10 fold growth of cells over a period of 21 days do not suggest a comparative
cell multiplication to the cells growing on a plate. This limitation maybe caused by the microscaled contours on the surface of the scaffold. No significant evidence of three-dimensional
cellular growth was observed from live/dead staining. In particular, 10% PLLA scaffold cooled at
10°C/min displayed higher cell growth with its mean pore-size lower than 7% PLLA scaffolds by
~4µm.
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Figure 4.3. Fold increase of DNA representing cellular growth in PLLA scaffolds (7% and 10% cooled at 1, 10 and 40°C/min, 1 mm
thick) at time points 7, 14 and 21 days relative to DNA quantity of initially loaded cells. *indicates weak statistical significance (0.05
< p-value < 0.1); **indicates not significant (p-value > 0.1) (n=9)
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Figure 4.4. Live cells (green) and dead cells (red) in control and PLLA scaffolds (7% and 10%
cooled at 1, 10 and 40°C/min, 2 mm thick) during time points 3, 21 and 42 days
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Table 4.1. Viability (%) of human adipose stem cells
7%
Days

10°

10%
40°

1° C/min

10°

40°

C/min

C/min

control

1° C/min
C/min

C/min

3

96.64 %

93.09 %

96.23 %

97.95 %

93.79 %

96.78 %

99.78 %

21

98.10 %

96.76 %

98.90 %

99.58 %

96.36 %

98.72 %

99.96 %

42

99.75 %

99.36 %

99.11 %

99.78 %

99.97 %

99.36 %

99.98 %

Figure 4.5. Zoomed-in image of live/dead staining showing both live (green) and dead (red)
cells

Table 4.1, shows that the percentage viability increases consistently with time. Two- tailed
student’s t-test showed no significant difference between any of the scaffolds or control at a
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particular time point. The relatively low % viability in scaffold at day 0 could be due to the initial
difficulty in attachment of hASCs. However, as time progresses the % of live cells increases
consistently to be on par with control at day 42. Also from Fig.4.2, we observe abundant cell
growth three dimensionally on the scaffold at this time point.

Figure 4.6. Three-dimensional cellular growth of hASCs (yellow) on scaffolds (transparent
white) made using initial concentration of 7% (wt/v) PLLA/dioxane

Interestingly the cell growth was abundant around the edges of scaffolds as observed at day 21 in
Fig.4.2 (shown for some scaffolds). This could be because of the relative long pore-sizes on the
edges of the scaffold caused by higher thermal flux during the cooling process. Alternatively, it
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could be because the cells preferred a location with more exposure to stromal medium. However,
at day 42, homogenous growth of cells on the surface of the scaffolds was observed. At this time
point the viability (%) of hASCs on all scaffolds were measured to be > 99%. Thus, PLLA
scaffolds prepared by TIPS method with controlled cooling rate provide no cytotoxicity to hASCs.
The hydrophobicity of PLLA does not hinder cell adhesion and proliferation.

Figure 4.7. Three-dimensional cellular growth of hASCs (yellow) on scaffolds (transparent
white) made using initial concentration of 10% (wt/v) PLLA/dioxane

Growth of hASCs within the three-dimensional constructs can be observed in Fig 4.6 and 4.7 with
the passage of time. More confluence of cells was observed in the outer peripheral regions of the
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scaffolds on the loading surface. The depth of cellular growth in the axial direction was
approximately measured using NIH ImageJ software. The maximum growth in the axial region
was about 1 mm in scaffolds made using 10% PLLA concentration and 10°C/min cooling rate.
Although these measurements may not be accurate due to uneven scaffold surface during cutting
before cell culture. Overall lack of cell penetration in the axial direction could be because of low
mean pore-sizes. High confluence of cells was observed in the scaffolds made using 7% PLLA
concentration cooled at 1°C/min and 10% PLLA concentration cooled at 10°C/min. This can be
correlated with high cellular growth observed in DNA quantification for these scaffolds. It should
also be noted that the SKYSCAN 1074 microtomograph has a resolution of 37 µm which is about
4 times smaller than the size of a hASC. Therefore, the regions detected by the scanner should be
having a high confluence of cells, which were focused on the top surface.

Figure 4.8. Preference of hASCs to the circumferential regions on a scaffold
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Fig 4.8 represents a common trend observed in preference of hASCs to multiply rapidly at the
outer circumferential regions of the top surface on the scaffolds. This trend was observed in
scaffolds made using all parameters as shown in Fig 4.4, 4.6 and 4.7. As discussed in chapter 2
and 3, spindle shaped pores with larger lengths, propagating in the radial direction were found in
the SEM images of the vertical section of scaffolds. Relatively larger pore sizes (>100 µm) could
be one of the reasons why hASCs prefer the circumferential regions of a scaffold. Exposure of
more surface to stromal medium could also be an additional factor causing this phenomenon.
4.4. Conclusion
Thus, this study compares the performance of PLLA scaffolds made by conducting extensive
parametric TIPS fabrication. Human adipose derived stem cells were cultured on these scaffolds
to measure the cell growth in the three dimensional PLLA constructs in terms of increase in DNA
quantity. The intra-scaffold cell proliferation of hASCs suggests that the hydrophobicity of PLLA
does not impede its bio-compatibility. Further, the viability increases consistently on the scaffold
over a period of 42 days. This suggests that such optimally tailored PLLA scaffold could be a
prime candidate for making surgically implantable tissue grafts exvivo [163, 164]. These tissue
grafts could provide an efficient and viable alternative to current autologous bone grafting
methods. Future osteogenic studies will be conducted on human adipose derived adult stem cells
(ASCs) [125, 165, 166] in cohesion with optimally structured and strengthened PLLA scaffolds.
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Chapter 5 : Osteogenesis of Human Adipose Derived Stem Cells on Cellular Responsive
PLLA Scaffold
5.1. Introduction
There are three important features for an ‘ideal’ graft material used in a bone graft. (i)
Osteoconductive: facilitates the ingrowth and integration of adjacent bone; (ii) Osteoinductive:
undifferentiated pluripotent cells are stimulated to develop into the bone-forming cell lineage. One
proposed definition is the process by which osteogenesis is induced and; (iii) Osteointegration:
implanted bone graft get fused in the defect site homogenously [167-171]. Many synthetic polymer
materials which has been studied in osteo-differentiation of precursor cells and reported to be
‘osteo-inductive’, have used chemical osteo-induction in the growth media. PLLA also has a
similar fate where almost no in vitro study has been focused on whether PLLA as a material is
osteo-inductive by itself. In this chapter, the osteo-inductivity of PLLA in relation to the chemical
inductive differentiation is being reported.
5.2. Materials and Methods
5.2.1. Ideal Scaffold from Thermal Profile Variables
Varying the cooling rate and the PLLA concentration did produce significant difference in poresizes, porosity (%) and compressive modulus. But the real competence of a scaffold is proved by
its cellular growth response. Due to its influence for robust cellular growth, scaffolds made by
10% (wt/v) PLLA/dioxane cooled at 10°C/min was used for osteogenic study. These scaffolds
were trimmed to 1 mm in thickness for cell loading.
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5.2.2. Cell Culture and Loading
After 2 passages, hASCs were trypsinized from T-150 flasks (Corning, USA) and suspended in
stromal media (SM) at 106 cells / mL. About 500,000 cells were loaded on PLLA scaffolds (fixed
on a 6-well plate by 1% agarose gel) and on 6-well plates as a control. The scaffolds and control
were divided into two groups: one was cultured in stromal media (DMEM high glucose, 10% fetal
bovine serum, 100 IU penicillin/mL, 100 μg streptomycin/ml, and 25 μg amphotericin/mL) and
another group was cultured in osteogenic media (OM) (DMEM high glucose, 10% fetal bovine
serum, 100 IU penicillin/mL, 100 μg streptomycin/ml, 25 μg amphotericin/mL, 50 µg/ml ascorbic
acid, 10 mM β-glycerophosphate and 100 nM dexamethasone). All media were changed every 3
days and fresh media was prepared for each change.
5.2.3. Alizarin Red Staining
At time points 7, 14, 21 and 28 days the cells growing as control on 6-well plates were fixed with
70% ethanol in DPBS (without Ca, Mg) (Gibco, USA) at 4°C for 20 mins. Then washed with deionized water (DI H2O). Then the samples were stained with 1mL of 40mM Alizarin Red S
solution in DPBS (without Ca, Mg) per well, at room temperature for 20 mins. Alizarin red S can
stain calcium deposits through interaction of its sulfonic acid and hydroxy groups with calcium
ions [172, 173]. The staining solution was removed and washed with DI water until no further
stain was washed away. At time points 7, 14 and 21 days, the scaffolds were washed with DPBS
before fixing and staining with the same protocol mentioned above. The stained scaffold samples
were washed with DI H2O for 48 hrs on a rocker, changing the water every 12 hrs. After 48 hrs no
further stain was removed from the scaffolds.
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5.2.4. RNA Extraction
RNA extraction from PLLA scaffolds by commercial reagents TRI Reagent® (Sigma) or TRIzol
RNA Isolation Reagents (Thermo Fisher Scientific) did not provide a high yield ( < 10 ng) after
21 days in culture. Also, the A260/280 and A260/230 values were lower than one suggesting that the
RNA in the template was not purified of other nucleic acids and other organelles respectively. An
alternate product known as PureLink RNA Mini Kit (Thermo Fisher Scientific) provided the
necessary purification equipment by means of spin cartridges. The membranes in the spin
cartridges selectively binds to the RNA molecules, thus making further purification possible. After
homogenizing the hASC - PLLA scaffold composites using 7 mL Dounce tissue grinder (SigmaAldrich, USA), with lysis buffer provided by the manufacturer, an extra centrifugation step was
added to remove the debris from the scaffold. A calibration experiment was conducted to find an
optimal centrifugation speed and time. Centrifugation was done using Minispin® Plus (Eppendorf,
NY, USA). Five different centrifugation speeds were used for 5 min time period. Higher
centrifugation speeds will cause higher heat generation which may lead to the degradation of
nucleic acids and also affect the quality of the templates. It was found that the highest yield without
compromising the quality was obtained at 5000 rpm. However, better quality maybe obtained
when centrifuged for lower time periods. To test this hypothesis, the samples were centrifuged at
5000 rpm for 3 mins. It was found that the quality of the RNA template was compromised with
other cellular debris indicated by A260/230 value. Table 5.1 shows that the quality of RNA at 5000
rpm for 5 min was the highest. Ideal A260/280 and A260/230 values are 2.
Thus, after homogenization of PLLA scaffolds, an additional centrifugation for 5 mins at 5000
rpm was performed before following the manufacturer’s protocol to obtain the final RNA template.
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Table 5.1. Calibration of centrifugation step
Speed (rpm)

Time (min)

- (Lysis buffer added on top)

A260/280

A260/230

ng/µL

1.71

0.54

10.9

2,000

5

1.90

0.83

26.0

3,000

5

2.06

1.42

20.6

5,000

5

1.99

1.97

26.4

8,000

5

1.83

0.09

3.96

10,000

5

2.06

0.75

33.1

5,000

3

2.19

1.41

38.7

5.2.5. Quantitative Polymerase Chain Reaction (QPCR)
High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems, CA, USA) was used for
the transcription of RNA to cDNA template following manufacturer’s protocol. Real-time qPCR
was done to measure the upregulation of alkaline phosphatase (ALP) and Runt-related
transcription factor 2 (Runx2). ALP and Runx2 are two important early expressing genes during
osteogenic differentiation pathway. Runx2 is plays an important role during the differentiation of
mesenchymal stem cell into an immature osteoblast. Peptidylprolyl isomerase B or cyclophilin B
(PPIB) was used as a reference gene for relative quantification of ALP and Runx2 uptake. Power
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SYBR Green PCR Master Mix (Applied Biosystems, CA, USA) reagent kit was used following
the manufacturer’s protocol in MiniOpticon Real-Time PCR System (Bio-Rad, CA, USA).

Table 5.2. Nucleotide sequence of the primers used
Gene

Forward primer (5’ - 3’)

Reverse primer (5’ - 3’)

ALP

CAAGGACGCTGGGAAATC

CGTCAATGTCCCTGATGTTAT

Runx2

GGACGAGGCAAGAGTTTC

GGGACACCTACTCTCATACT

PPIB

CTACAGGAGAGAAAGGATTTGG AGCCGTTGGTGTCTTTG

5.3. Results and Discussion
In Fig. 5.1, it can be observed that there is an increase in the staining of alizarin red on scaffolds
cultured in both stromal as well as osteogenic medium. The uptake of stain is more vigorous in
scaffolds cultured in osteogenic media. In Fig. 5.2, it is found that the calcification takes 28 days
to appear in hASCs cultured on plate and induced osteogenesis by chemicals (50 µg/ml ascorbic
acid, 10 mM β-glycerophosphate and 10 nM dexamethasone). Alizarin red stains only the nodal
calcium deposits among the osteoblast growth. This is the last stage of differentiation of hASCs
into osteoblast phenotype. A significant uptake in PLLA scaffolds grown in OM is observed even
at day 21 (7 days before OM induces osteogenesis in positive control). Therefore, it can be inferred
that PLLA definitely plays a role in osteogenic induction of hASCs. Further evidence is given by
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hASCs cultured on PLLA scaffolds with SM. Therefore, PLLA is definitely osteo-inductive
without other methods of osteo-induction.

Figure 5.1. Alizarin red S staining of PLLA scaffolds cultured in stromal and osteogenic media
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Figure 5.2. Alizarin red S stain of hASCs cultured in stromal and osteogenic media

The alizarin red stain from the samples were eluted using 10% cetylpyridinium chloride (CPC) in
DI water. For positive and negative controls (hASCs in OM and hASCs in SM respectively),
incubating the stained samples with 1 mL of 10% CPC at room temperature for 20 mins will
successfully remove all the stains. For stained samples of PLLA scaffolds, the constructs were
homogenized using a 7 mL Dounce tissue grinder with 1 mL of 10% CPC, incubated at room
temperature for 20 mins. The solution was centrifuged at 1500 rpm for 2 mins to remove the PLLA
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debris from homogenization and to obtain a clear supernatant with only CPC bound alizarin red.
These CPC bound alizarin red solution were quantified using Wallac Victor2 Plate reader to
measure the absorbance at 531 nm wavelength.

Figure 5.3. Quantification of alizarin red staining (n = 3)

The absorbance values were corresponded to a concentration of alizarin red using a known
standard curve. The exact amount of alizarin red obtained was normalized with the surface area of
scaffolds (exposed to growth medium) and controls, since most of the cell growth were on the
outer surface of the scaffolds (as observed by three dimensional scans). Human adipose stem cells
cultured on PLLA scaffolds with stromal medium showed no statistical increase from day 14 to
day 21. However, the calcification concentration of scaffolds in SM (0.22 µM/cm2) were higher
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than the negative control (0.03 µM/cm2) as well as the positive control (0.0522 µM/cm2) at day
14. At day 21, there was increased calcification for all samples except the negative control (0.038
µM/cm2). Calcification concentration of positive control was 0.09 µM/cm2, scaffolds in SM was
0.2 µM/cm2 and scaffolds in OM was 0.36 µM/cm2. Continued increase in calcification was
observed at day 28 suggesting that the hASC - PLLA scaffold composites are committing towards
a bone graft formation.

Figure 5.4. Expression of (A) ALP and (B) Runx2 genes at 14 and 28 days (n = 3)
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The negative control was used to normalize and measure the up/down regulation of ALP and
Runx2 at 14 and 28 day time points. The expression of ALP is increased from 3.27 ± 0.3 to 4.94
± 1.5 fold in the positive control, from 1.36 ± 0.59 to 3.52 ± 2.18 fold in scaffolds in SM and from
4.16 ± 0.01 to 19.49 ± 0.66 fold in scaffolds in OM from day 14 to day 28. The expression of
Runx2 was regulated as from 3.15 ± 1.07 to 4.32 ± 1.11 fold in the positive control, from 7.26 ±
1.12 to 3.14 ± 0.79 fold in scaffolds in SM and from 5.96 ± 0.65 to 4.86 ± 0.24 fold in scaffolds in
OM from day 14 to day 28. The down regulation of Runx2 observed in scaffolds (cultured in both
SM and OM) from 14 to 28 days suggests that the hASCs have crossed the immature osteoblastic
stage during its differentiation pathway. Thus, suggesting that between 14 and 28 days mature
osteoblasts are being formed. However more studies should be conducted to study the expression
of other osteoblast specific genes like osteocalcin, osteopontin, SP7 etc., to exactly track the states
of stem cells along the osteogenic pathway. The quantity of RNA and subsequently the cDNA was
not enough to measure the expression of osteocalcin. About 10 ng of cDNA template was used for
each reaction. Therefore, more number of cells should be loaded initially to obtain enough RNA
template, to measure the expression of low sensitive, osteoblast specific genes in future studies.
5.4. Conclusion
A set of porous three-dimensional constructs made of PLLA was developed by varying thermal
profiles and PLLA concentration. Based on the characterization an ideal parameter for making a
robust viable scaffold was selected, particularly based on cellular proliferation in the threedimensional construct. This scaffold was studied for osteogenic differentiation potential on
hASCs. It was found that PLLA is osteo-inductive by nature without any external signaling. Hence,
PLLA scaffolds combined with hASCs is an excellent method to form bone graft, which can be
used for treatment procedures similar to Lendenckel et al [69].
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The PLLA scaffolds supported uninhibited cellular growth as measured by DNA quantification
over a period of 21 days. At longer periods of culture (42 days), the cytotoxicity was practically
null relative to hASCs grown on control plates. However, more research should be done to
encourage three-dimensional cellular growth as most of the scaffolds exhibited a resistance for cell
permeation inside its construct. This could be because of relatively low pore-sizes (~90 µm).
Further studies should be conducted to increase the mean pore size, by experimenting with
alternate shapes/sizes of capsules to be used in controlled cooling methods. Viability of cells post
cryo-preservation should be conducted to learn if the bone grafts are suitable for storage and future
use.
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Chapter 6 : Future Directions for Making Ex-vivo Tissue Engineered Bone Grafts
Current concepts of making tissue engineered bone grafts incorporates osteoblast progenitor cells
and a structural construct which serves a substrate for the cells to grow and also to withstand
mechanical stresses experienced in a host bone in vivo. This study primarily investigates using
Poly (l-lactic acid) as a material to fabricate a three-dimensional porous construct using thermally
induced phase separation method. Human adipose stem cells were used as the progenitor cells due
to their simple extraction procedures and abundant availability. Future studies should be conducted
to study the structure-property out comes of scaffolds made using vials different shaped vials like
UV-Transparent Spectrophotometry Cuvettes (VWR, TX, USA). Vials of smaller dimensions (5 6 mm diameter) would be a rational option as abundant cellular growth was observed in regions
on the scaffolds nearest to the glass contact. However, using glass vials should be preferred over
other materials for practical reasons. Using copper, aluminum or polystyrene had practical issues
of removing the scaffold after lyophilization.
Other biodegradable, FDA approved polymer materials like poly (glycolic acid) (PGA), poly
(lactic-co-glycolic acid) (PLGA), Polycaprolactone (PCL) should be used to make scaffolds
adopting a similar procedure to study its structure-property results and bio-responsivity in terms
of cellular growth and osteoinduction. Polymer-ceramic composite materials should be considered
for future studies as ceramics compounds like hydroxyapatite and calcium phosphate cements
would increase the mechanical strength of the scaffolds. A tricalcium phosphate compound (βTCP)
was used in conjunction with PLLA/dioxane solution at varying concentrations (10:90, 30:70 and
40:60 (PLLA:dioxane)). Following lyophilization, βTCP was lost in an imprecise manner due to
lack of fusion between PLLA and βTCP. Therefore, ideal methods of fusing such ceramic
compounds with polymer materials should be designed before using thermally controlled phase
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separation method for scaffold fabrication. Also, some of the other solvents for most polymers like
benzene, chloroform and cyclohexane should be used to make scaffolds using controlled,
thermally induced phase separation method to study its structure-property outcomes. High toxicity
of chloroform and benzene are the concerning factors in the context of cellular growth and
cytotoxicity.
The greatest challenge in conducting cellular experiments on an opaque thermoplastic substance
is the high adherence of hASCs on the scaffold material. Trypsin (0.05%) had to be used in higher
quantities (> 6 mL per hASC - scaffold composite) for longer duration (> 10 mins) to remove
hASCs from the scaffold substrate, damaging majority of the cells in this process. Finding a more
efficient way to extract hASCs from the scaffold without causing major artifacts in the structure
would lead to the possibility of many specific and quantitative assays like flow cytometry, alamar
blue based metabolic assay, accurate quantification of RNA and protein expression. For
osteoinduction medium, 100nM of dexamethasone was used in this study. However, recent studies
have reported using 10nM of dexamethasone with earlier induction of osteogenesis on
mesenchymal stem cells. Therefore, the osteogenic experiments should be conducted with 10nM
concentration of dexamethasone to comparatively study advancement of osteogenesis (earlier
expression of calcification and osteoblast specific RNA).
Effects of cryo-preservation of tissue engineered bone grafts should be studied in future. Various
cryoprotectants such as dimethyl sulfoxide (DMSO), Polyvinylpyrrolidone (PVP), ethylene glycol
and glycerol. These experiments should be focused on calibrating a suitable time for
cryopreservation after loading hASCs on scaffolds. Early cryopreservable hASCs - scaffold
composites would be ideal for industry specific needs. Viability, cellular growth and
Osteoinductive potential of hASCs/osteoblasts before and after cryopreservation should be
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studied. Such bio responsive bone grafts, post cryopreservation would enable patients to create
and store customized bone grafts from their own stem cells in case of future requirements. Thus,
successfully tissue engineered, cryopreservable bone grafts would be a major clinical breakthrough
in terms of treating large scale skeletal defects requiring external bone graft implantation.
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